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ABSTRACT OF THE THESIS

DETERMINATION OF THE EXTRAVASCULAR BURDEN OF CARBON
MONOXIDE (CO) ON HUMAN HEART
Noninvasive measurements of myocardial carboxymyoglobin levels (%MbCO) and
oxygen tensions (PtO2) are difficult to obtain experimentally. We have developed a
compartmental model which allows prediction of myocardial %MbCO levels and PtO2
for varied carbon monoxide (CO) exposures. The cardiac compartment in the model
consists of vascular subcompartments which contain two tissue subcompartments varying
in capillary density. Mass-balance equations for oxygen (O2) and CO are applied for all
compartments. Myocardial oxygen consumption and blood flow are quantified from
predictive formulas based on heart rate. Model predictions are validated with
experimental data at normoxia, hypoxia, exercise and hyperoxia. CO exposures of
varying concentration and time (short-high, long-low), CO rebreathing during 100% O2,
and exposure during exercise is simulated. Results of the simulations demonstrate that
during CO exposures and subsequent therapies, the temporal changes of %MbCO in the
heart differ from those of carboxyhemoglobin levels (%HbCO). Analysis of correlation
between %HbCO, %MbCO and PtO2 was done to understand myocardial injury due to
CO hypoxia. This thesis demonstrates that the model is able to anticipate the uptake and
distribution of CO in the human myocardium and thus can be used to estimate the
extravascular burden (MbCO, PtO2 ) of CO on the human heart.
Key words: Myocardial Oxygen Tension, CO Hypoxia, Exercise, Tissue Oxygenation, Cardiac
Muscle
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CHAPTER 1
Introduction
Chapter 1 explains the importance of the need for developing a model for
predicting the extravascular burden of CO on the human heart. The chapter gives a
basic introduction to carbon monoxide (CO) toxicity, and details the sources of CO,
reactions of CO with the heme pigments in the body and the effects of CO exposure
on oxygen (O2) delivery to tissues. This chapter discusses the symptoms, effects and
treatment strategies of CO poisoning cases. Finally, the chapter highlights the
hypothesis made and goals to be achieved in the following thesis.
1.1 Carbon Monoxide (CO) Toxicity
Carbon Monoxide (CO) is a byproduct of incomplete combustion of carbonbased fossil fuels. CO is generated in toxic amounts by internal-combustion engines,
faulty fossil-fuel heating systems, fire accidents, and emissions from modern
automobiles in poorly ventilated spaces. The body produces CO as a by-product of
hemoglobin degradation, but the gas does not reach toxic concentrations in vivo
unless it is inhaled from exogenous sources (like faulty heaters, indoor charcoal grills,
cigarette smoke, swimming behind a motorboat or under a houseboat, etc.). Carbon
monoxide, which is a colorless, tasteless and odorless gas, is often referred to as an
invisible killer as it is difficult to detect. Exposure to CO concentrations exceeding
permissible exposure levels (PEL) of 50 ppm over an average of 8 hrs (1, 2) is a
significant environmental and occupational health concern. There are approximately
4000 deaths per year occurring in United States due to CO poisoning (3, 4, and 5).
CO exposures and poisonings occur more often during the fall and winter, when
people are more likely to use gas furnaces, heaters and generators in their homes (4,
6).
CO produces tissue toxicity by impairing oxygen (O2) delivery to the tissues.
CO is absorbed by the respiratory tract and diffuses through the alveolar-capillary
membrane and enters the blood, following a path similar to that of O2. The rate of
absorption of CO decreases when the partial pressures of CO in blood of the
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pulmonary capillaries and the alveolar air reach a state of equilibrium. After being
absorbed and diffusing through the respiratory tract, CO combines reversibly with the
heme pigments of the body, namely: (i) Hemoglobin (Hb) present in blood (ii)
Myoglobin (Mb) present in muscle tissues, and (iii) other membrane bound hemecontaining compounds (e.g., cytochromes). Hemoglobin (Hb) is a tetrameric heme
protein present in red blood cells whose main function is oxygen (O2) transport
(Figure 1.1.1). O2 is stored in the lungs as a gas and in the blood. In the blood it is
present in two (7) forms: (i) dissolved in plasma (normally 1.5% or 3 ml in 1 liter
blood) and (ii) reversibly combined with hemoglobin (normally 98.5% or 197 ml in 1
liter blood). Each hemoglobin molecule can bind to four oxygen molecules forming
fully-saturated oxyhemoglobin (O2Hb), (Figure 1.1.2). Hb binds CO ~220 times more
strongly than it binds O2, to form carboxyhemoglobin (HbCO) (Figure 1.3.1).
Myoglobin (Mb) is a monomeric heme protein present in muscle tissue
(Figure 1.2.2) and each myoglobin molecule can bind to one oxygen molecule
forming oxymyoglobin (O2Mb) (Figure 1.2.1). It is an oxygen store and also binds to
CO to form carboxymyoglobin (MbCO) (Figure 1.2.3). Mb binds CO ~36 times more
strongly than it binds O2.
Thus CO toxicity causes mortality primarily due to the effects of severe
hypoxia by attaching itself to Hb and Mb and reducing the oxygen carrying capacity
of these heme proteins. CO usually replaces only two of the four O2 molecules bound
to the heme groups of hemoglobin. In cases of high CO concentrations it is possible
that CO may replace the third O2 molecule by binding to the third heme group (Figure
1.3.2). Thus CO toxic hypoxemia causes changes in the circulatory, respiratory and
metabolic demands of the tissue (8-18).
Groups especially susceptible to the hypoxic stress of carbon monoxide
exposure would potentially be individuals with cardiovascular and obstructive lung
diseases, individuals with cerebrovascular and peripheral vascular diseases, and
individuals with anemia. In addition, hospitalized individuals suffering from tissue
hypoxia (e.g. shock) or those undergoing operations may be at increased risk.
Individuals with undetected or undiagnosed coronary artery disease as well as the
fetus, the newborn or, even pregnant women may be assumed to be at increased risk
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because of the anticipated reduced capacity to accommodate hypoxic stress or some
inherent sensitivity to hypoxia. Furthermore, other populations such as those living at
high altitudes, young children, or older adults may also be at increased risk (2).

1.2 Symptoms, Diagnosis and Treatments of CO Poisoning
Symptoms and effects of CO poisoning are greatly dependent on the
concentration and duration of exposure. CO poisoning could be acute (exposure to
CO occurs and lasts no longer than 24 hrs) or chronic (exposure to CO that occurs
more than once and lasts longer than 24 hrs). Generally, chronic exposures involve
lower HbCO saturations due to lower CO exposures. Diagnosis of CO poisoning is
difficult unless the event of toxicity occurs at site of high CO concentration like a
house on fire or a blast in a coal mine. CO poisoning can be difficult to diagnose
because CO poisoning symptoms are similar to those of flu. Specific information
regarding the CO exposure duration and the concentration of CO inhaled is often
unavailable. In addition valid blood HbCO level measurements are readily obtained
but are an unreliable predictor of injury, and there are no clinical tests that can
determine the extra vascular burden of CO (e.g., a noninvasive measurement of
MbCO levels or tissue PO2 in humans). Although CO poisoning does not cause a
fever, other symptoms are similar to those of the flu (including nausea, severe
headache, vomiting) and also include neurological sequellae (memory loss,
personality and behavior changes, brain damage etc), cardiac abnormalities in ECG,
abnormal ventricular function and elevated cardiac biomarkers diagnostic of
myocardial injury depending on the type of CO exposure. Treatment for CO poisoned
victims involves administering supplemental O2. The treatment is with either
normobaric hyperoxia, where 100% Oxygen (O2) is administered if the victim is
conscious and HbCO levels in the blood are less than 25%, or hyperbaric hyperoxia
where 100% Oxygen (O2) is administered, at 1-3 ATA (1 atmosphere = 760 mm of
Hg) pressure, if the victim is unconscious or the HbCO level exceeds 25%. However,
there are some problems with the treatment strategies for CO poisoning victims.
Decision of the treatment protocol is based on the measured HbCO levels in the
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venous blood. Blood %HbCO is readily measurable but is thought to be an unreliable
measure of poisoning severity. Carboxymyoglobin (MbCO) levels and tissue partial
pressures of oxygen (PO2) which are more reliable indicators of CO toxicity in the
tissue are difficult to measure through any clinical procedures. Treatment strategy is
often debatable and it may not be very clear whether hyperbaric hyperoxia rather than
normobaric hyperoxia treatment is necessary (19, 20, 21, 22, 23). Despite treatment
after CO poisoning, neurological and cardiac sequellae often occur.

1.3 Motivation for the Thesis
CO hypoxia results in impaired O2 delivery causing a decrease in O2 uptake by
the cells. This diminished O2 utilization causes alterations in biochemical (cardiac
troponin I, phosphocreatine (PCr), lactate) and physiological (cardiac output, rate
pressure product, metabolic rate) activities. Elevated cardiac biomarkers (cardiac
troponin I ≥ 0.7ng/ml, CK-MB (Creatine kinase MB isoenzyme) mass ≥5.0ng/ml)
and diagnostic EKG (electrocardiogram) changes (like ST segment elevation, Twave changes), abnormal left ventricular (LV) function (like alternations in left
ventricular ejection fractions) and regional wall motion abnormality are observed in
moderate to severely CO poisoned patients (24). In a population of 230 CO poisoned
patients, 44% of deaths were reported to be due to cardiovascular causes such as
cardiac arrest, myocardial infarction, congestive heart failure, fatal arrhythmia (24).
Also, there is evidence that workers who are exposed to high CO concentrations
have an increased risk for cardiovascular morbidity and mortality (25, 26). The effect
of high CO exposures would pose a greater risk for injury during exercise, as there
would be increased demand for O2 in the tissue accompanied with O2 impairment due
to CO binding to hemoglobin and myoglobin. Exercise also increases ventilation
which, in turn, increases the amount of CO inhaled and thus the dose of CO.
Coronary circulation is very sensitive to O2 deprivation as the myocardium has
a very high O2 extraction fraction (Measure of quantity of O2delivered to the tissue
and is defined as ratio of arterial and venous (A- V) O2 concentration difference and
arterial (A) O2 concentration) to causing profound effects of CO in the myocardium.
Each molecule of myoglobin in the heart is capable of binding to one CO molecule by
4

means of the heme group to form carboxymyoglobin (MbCO), which would further
increase the CO content in the heart tissue causing a decrease in O2 availability. Also,
the contribution of myoglobin diffusion during CO hypoxia is unclear (27, 28, 29).
All the above recent reports on cardiac impairment, occurring with CO poisoning
motivated scientists to understand the causes of cardiovascular abnormalities in CO
poisoning victims (30, 31, 32). Therefore, keeping these facts in mind, the following
hypothesis was made for the thesis:

Hypothesis: “During CO exposures and subsequent therapies, the temporal changes
of %MbCO in the heart differ from those of %HbCO; in particular, there are times
during the therapy %MbCO can sometimes increase when %HbCO is decreasing”.
The importance of this hypothesis is that CO load delivered to the heart impairs
oxygen delivery, further affecting the tissue oxygen tension (PtO2) and O2 pressure
gradients. This CO load is related to both %HbCO in arterial blood perfusing the
heart and %MbCO in cardiac tissue. If %MbCO and %HbCO change in opposite
directions, then the currently-used clinical indicator of potential injury (i. e., %HbCO)
will be inaccurate and possibly misleading. Thus, determining the total CO load on
the cardiac cells (or its effect on tissue PO2) might be a better predictor of injury.
1.4 The Need for our Model
Determination of the burden of CO (vascular - %HbCO and extra vascular %MbCO) and its effects on tissue PO2 during uptake and washout would provide a
better assessment of risk associated with a range of exposure conditions in CO
toxicology. This specific task can be accomplished in two ways:
1. Conduct experiments involving CO exposures
2. Estimate CO burden from a “Mathematical Model”
Conducting experiments involving low CO exposures can be accomplished in
human subjects, but it would be unethical to expose subjects to high CO exposures to
understand causes of injury due to CO and predict clinical outcomes. Also, these
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experiments are difficult to conduct and require detailed care, great expertise and are
also expensive. Even if these experiments are conducted, non-invasive measurements
of MbCO are not possible. Also, invasive or non-invasive reliable measurements of
tissue oxygenation in healthy human hearts are difficult to make. Experimental
measurements of human myocardial O2 tension have been reported in patient
populations with cardiovascular abnormalities (33, 34). Thus, the best option would
be to build a model to predict the burden (vascular-HbCO; extra vascular- MbCO) of
CO on the human heart by doing simulations for a range of CO exposures. If one can
implement O2 interaction equations, the model can also help to predict oxygen
tension in the heart. Further, the model can be used to anticipate levels of CO that
may be lethal to the heart or to assess the risk of cardiac injury when exercise is
accompanied with CO exposure. This information would be helpful to design
treatment protocols for people exposed to CO while at work. Thus the approach I
decided to take to test the hypothesis is as follows:
Approach: “Since O2 and CO levels in heart are not measurable non-invasively in
humans, a plan to estimate these values from a model was made.”
After formulating a hypothesis, the next task was to assess the literature for the
availability of an appropriate model for predicting uptake and washout of CO. After
making a diligent search, the model developed in our lab by the authors of
reference 35 seemed most suitable. The process from setting an objective to reaching
a solution is summarized in Figure 1.4.
The reasons for selecting this model are explained in detail in section 2.1 of chapter 2.
This model consisted of lumped compartments for lungs, blood (arterial and venous),
skeletal tissue and non-muscle tissue. Mass balance equations for CO were used to
represent the compartments (35). However, this model also had some limitations and
so the model was further modified in our lab resulting in a better and more efficient
model (Bruce, Bruce, and Erupaka, in preparation) which, however, was still
inadequate for the present purposes because it did not include a compartment for the
heart. Figure 1.5 shows the different stages of model development. Thus, the next
task was to accomplish the following goals of the thesis to test the hypothesis made.
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The major goals of the thesis are:
(1) Introduce a two compartment cardiac block into the model.
(2) Implement mass balance equations for O2 and CO.
(3) Test and validate the model with experimental data for conditions of rest,
exercise, CO exposure and hypoxic hypoxia and hyperoxia.
(4) Use the developed and validated model to predict extravascular burden of
CO and O2 tension in the cardiac tissue during short-high concentration
CO exposures, CO rebreathing studies in 100% O2, long-low
concentration CO exposure, exercise in the absence and presence of CO,
and to determine CO concentrations injurious to the heart.
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Figure 1.1: Hemoglobin (Hb) and Oxyhemoglobin (HbO2). Hemoglobin (Figure
1.1.1) is a tetrameric heme protein present in red blood cells. O2 binds to the heme
(Fe) protein present in hemoglobin to form oxyhemoglobin (Figure 1.1.2).
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Figure1.2.1
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Figure 1.2: Oxymyoglobin (MbO2), Myoglobin (Mb), Carboxymyoglobin
(MbCO). Myoglobin (Figure 1.2.2) is a monomeric heme protein present in muscle
tissue. O2 binds to the heme (Fe) protein present in myoglobin to form oxymyoglobin
(Figure 1.2.2).CO also binds to the heme protein to form carboxymyoglobin (Figure
1.2.3 )
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Figure 1.4: Overview of the Thesis
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Figure 1.5: Stages of Model Development
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CHAPTER 2
Background

Chapter 2 provides information on models present in the scientific literature that
predict CO uptake and the limitations of these models. This chapter discusses the
basis for selecting a specific model for the thesis from the models present in the
literature and the necessity to modify the selected model to test the hypothesis made.
This chapter also gives a basic introduction to the concepts, simulation software used
and an overview of all the compartments present in the model. As it is difficult to
measure (non-invasively) carboxymyoglobin levels (MbCO) and tissue O2 tension
(PtO2) in the human heart, building a model for estimating these parameters seemed
the best approach. Modification may include implementing desired features to cater to
the needs of the desired model and to overcome the limitations of the available
models.
2.1 Previous Models
The CFK (Coburn Forster Kane) model often discussed in the carbon monoxide
level (CO) literature predicts carboxyhemoglobin (COHb) levels for acute and
chronic CO exposures (Coburn et al. 1965). The CFK equation establishes a relation
between the blood COHb levels, rate of endogenous CO production, and CO
exchange rate due to respiration. However, this model has certain limitations. For
example, the model lumps the total blood volume into a single homogeneous, well
mixed compartment and also excludes the dissolved CO or oxygen (O2) in the blood
while determining the COHb levels in the blood. The CFK model analytically solves
the linearized CFK equation by assuming a constant O2Hb concentration in the blood.
The model predictions agree well with experimental values under normal
conditions but disagree with experimental values involving transient CO exposures
(154), involving fast reactions of CO with Hb (Forster (1970), Holland (1970),
Roughton (1964), Waller et.al (1988)). Later Peterson & Stewart (1975), Bernad &
Duker (1981), Tyuma et. al (1981) and Collier & Goldsmith (1983) solved the CFK
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equation by accounting for the variation of O2Hb using iterative methods, analytical
solutions etc.
More recently, a mathematical model was developed (36) to predict alveolar
partial pressure of CO and blood HbCO as a function of exposure time and CO
concentration. CO uptake by blood was predicted taking into account the diffusion
based transport mechanisms of CO and the replacement reaction of CO with O2Hb.
Benignus et al. (1995) developed a model to predict blood COHb levels considering
variations in inhaled O2, CO2 and CO concentrations. But the drawback of these
models was that they limited their CO uptake predictions to the vascular
compartments. They did not include diffusion of gases from vascular compartments
to the surrounding tissue. This results in exclusion of extravascular storage sites of
CO like myoglobin present in muscle tissue and cytochrome oxidase in mitochondria.
Also, the concept of lumping blood into one single compartment results in loss of
physiological relevance related to variability in O2 concentrations (O2 content is
greater at the arterial side compared to venous side) and partial pressures present in
different blood subcompartments, which affects the predicted CO load.
Bruce (2003) developed a model that predicted distribution of CO in the body
by considering CO diffusion between the vascular and extravascular compartments.
The model (Figure 2.1) had a lung compartment, blood (arterial and venous)
compartments, muscle and non-muscle tissue with vascular and extravascular
compartments. Herein this model will be referred to as the primary model in this
thesis. Mass balance equations for CO were written for all the compartments of the
model and are described in detail in (35). An example of the mass balance equation
for CO for the alveolar compartment from the above model is as follows:
VL

dC A CO (t )
V.
= [ Pi CO (t ) − PA CO (t )] A − COflux LB (t )
dt
PB

where VL is lung volume, CACO is the alveolar CO concentration, PACO is the
alveolar partial pressure of CO (PCO), PiCO is inhaled partial pressure of CO, t is
time, and COfluxLB(t) is the CO flux from lungs to blood defined as
COflux LB (t ) = [ PA CO − ((1 − K v ) Pec CO (t ) + K v Pv CO (t − d v ))]DL CO
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where PecCO is end-capillary PCO, dv is the mean transport delay in mixed
venous blood, PvCO is mixed venous partial pressure of CO, and Kv is used to
apportion the effective pulmonary capillary PCO between the mixed venous and endcapillary pressures. Vascular mixing in the pulmonary capillary compartment is
ignored and CecCO is determined by adding COfluxLB to the mixed venous blood,
which enters the lungs after the mean transport delay (dv) from venous blood
compartments.
In the modified model (discussed in Section of 3.2 of chapter 3) and final model
(discussed in Section 3.3 of chapter 3) the same CO mass balance equations are used
for the alveolar compartment (as shown above) and the non-muscle tissue. For the
skeletal muscle (tissue and blood subcompartments), CO mass balance equations in
the final model (model developed for thesis) are described for two tissue
subcompartments and three blood vascular subcompartments, unlike equations used
for the single blood vascular and tissue compartments discussed in (35).
To determine the partial pressure of carbon monoxide (PCO) in each blood
compartment of the primary model it was necessary to solve three simultaneous
algebraic equations of O2 (discussed in Reference 35):
1. Oxyhemoglobin Dissociation Curve (ODC).
2. Haldane’s Equation.
3. Blood to Tissue Oxygen Flux Equations.
2.1.1 Oxyhemoglobin Dissociation Curve
The oxyhemoglobin dissociation curve gives the saturation of oxygen as a
function of the partial pressure of oxygen. There are number of factors that affect the
binding of oxygen to hemoglobin which change the shape of the curve. Factors that
affect the ODC are variation of the hydrogen ion concentration (pH), effects of
carbon dioxide, effects of 2,3-DPG (2,3-Diphosphoglycerate), temperature, carbon
monoxide, effects of methemoglobinemia (a form of abnormal hemoglobin) and fetal
hemoglobin (37). ODC is shifted to the right by an increase in temperature, 2, 3-DPG,
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or PCO2, or a decrease in pH. In this model, for the conditions that the authors intend
to simulate the most important factor that may affect the curve is the carbon
monoxide level. In the absence of CO, the sigmoidal shaped curve approaches a
horizontal asymptote as the partial pressure of oxygen exceeds approximately 70
mmHg and declines with a steep slope toward a point of inflexion when the partial
pressure of oxygen falls approximately below 60 mmHg. Carbon monoxide also has
the effect of shifting the curve to the left. Thus, a set of equations were derived to
represent the O2 dissociation relationship in the presence of CO by determining the
dependence of the Hill parameters on the HbCO level and then applying a correction
to the Hill equation at low O2 pressures. The method for the derivation is detailed in
the paper (35). When the inspired CO levels are zero, the ODC retains its shape.
Except at low PO2 values, a reasonable approximation to this curve for any given
level of HbCO is the Hill equation given below

CO 2

⎛ PO2
CO 2 (max) ⋅ ⎜⎜
⎝ P50
=
n
⎛ PO2 ⎞
⎟⎟
1 + ⎜⎜
⎝ P50 ⎠

n

⎞
⎟⎟
⎠ .

Where P50 = ap1 [1 + exp(ap 2 ⋅ %COHb )] − 1

and

n = an1 + an 2 ⋅ exp( −0.025 ⋅ %COHb)

ap1,ap2,an1, an2 are constants resulting from curve fitting for various
concentrations of CO. P50 is the PO2 necessary to half-saturate the Hb.
The ODC for Mb (Figure 5 of reference 38) is also represented by a Hill
equation, but it is assumed that its parameters are independent of the
carboxymyoglobin (MbCO) level except for that of the maximum O2-binding
capacity. At each time step of the simulation, the dissociation curve for Mb and the
Haldane equation for Mb are satisfied simultaneously via an implicit solution using an
iterative procedure.
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The Hill equation for myoglobin is

PO2 =

[O 2 Mb] ⋅ P 50
.
1 − [O 2 Mb]

where PO2 is the oxygen tension and [O2Mb] is the fractional O2 saturation of
myoglobin. P50 is the PO2 at which myoglobin is half-saturated with oxygen and is
dependent on temperature and pH.
2.1.2 Haldane’s Equation
PCO was determined by first solving for the other variables, assuming that PCO
is constant across an integration step, and then updating its value via the Haldane
equation as shown below.

MHbPCO
PO 2
=
COHb O 2 Hb
MHb is the Haldane affinity ratio for hemoglobin and has a value of 218. The
volumetric carrying capacity of Hb for O2 or CO is calculated as the product of Hb
concentration and the nominal maximum O2 content, 1.38 ml O2/g Hb. The Haldane
equation for myoglobin is

MMbPCO
PO 2
=
COMb O 2 Mb
MMb is the Haldane affinity ratio for myoglobin and has a value of 36. At each
time step of the simulation, the dissociation curve for Mb and the Haldane equation
for Mb were satisfied simultaneously via an implicit solution using an iterative
procedure.
2.1.3 Blood to Tissue Oxygen Flux Equations
The blood to tissue oxygen flux equations are described in (35). It was assumed
that O2 diffuses from the vascular to the extravascular subcompartments of the tissues
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at rates just sufficient to meet the metabolic demand of the tissue. Endogenous CO
production was included by assuming that all endogenous CO is delivered to the
mixed venous compartment.
2.2 Chosen Model and Proposed Modifications
The model (primary model) developed by Bruce (2003) fit the criteria of the
model needed for the thesis as the model accounted for transport of CO in the
pulmonary compartment, CO bound to Hb and dissolved in plasma, and transport of

CO from the blood flow to surrounding tissue. This model consists of five major
compartments: 1.The arterial blood, 2. The Lungs, 3. Skeletal Muscle, 4. Non-muscle
tissue and 5. Mixed venous blood compartments (Figure 2.1). Herein this model will
be referred to as the primary model in this thesis. However, O2 parameters were
assumed to be constant in this model and were passed as arguments.
Thus the primary model was chosen and certain modifications were proposed to
test the hypothesis made. The proposed modifications are as follows:
Tissue O2 tension which is an important predictor of the oxygenation state of the
tissue can also be anticipated by adding equations for O2 mass balances. This would
also aid in accounting for the nonlinearities in an efficient way.
The model predictions would be more physiologically relevant if the single
muscle compartment was divided into subcompartments. This would allow diffusion
of gases within the tissue resulting in better solution estimates for O2 tensions and CO
load. Therefore, in our lab we intended to replace the single lumped muscle
compartment with two subcompartments. Regional heterogeneity of blood flow and

O2 consumption in skeletal muscle demanded development of predictive equations to
calculate the arm, the trunk and the leg skeletal mass distributions. Also, a formula
was developed to predict an increase in cardiac output with increased COHb level in
blood. A paper on the updated model is in preparation (Bruce, Bruce, and Erupaka).
Though heart is a muscle tissue, it has a different morphology from skeletal
muscle tissue. Cardiac muscle has a different capillary density (39), resting blood
flow (Table 2.1) and metabolic rate (Table 2.2) from that of skeletal muscle (Table
2.3 and Table 2.4). Lumping the skeletal muscle and cardiac muscle into a single
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compartment would not be a good assumption to make. Thus, it would be important
to add a heart compartment to the model in order to model CO uptake and PO2 in the
myocardium and relate them to cardiac injury.
Another objective was to develop better and more efficient algorithms to
determine PO2 and PCO in the compartments. The algorithms used in the primary
model had convergence issues while solving the O2 dissociation curves of Hb and Mb
(especially solving for PO2 and PCO when certain conditions caused ODC to be flat)
and resulted in numerical errors. It was also important to modify the blood to tissue
oxygen flux equations by evaluating them as a function of pressure gradients and
diffusion coefficients of O2 instead of making an assumption of equality between O2
flux and metabolic demand of the compartment.
2.3 Basic Concepts of the Model
The basic concept used in developing the model is the continuum theory of
conservation of mass. Figure 2.2 gives a summary of basic concepts needed to build a
model. Mass balance equations are written for CO and O2 for all compartments. Mass
balance equations state that for any substance Q in a compartment,
dQ / dt = (rate of inflow + rate of creation) – (rate of outflow + rate of destruction)

The model diagram and dynamic equations are described in detail in chapter 3.
The simulation tool or software used to apply principles of physiology and
engineering to a model is ACSL (Advanced Continuous Simulation Language). This
tool has been exclusively developed for the purpose of modeling systems described
by time dependent, non-linear differential equations or transfer functions. ACSL
application areas include control system design, missile and aircraft simulation,
power plant dynamics, biomedical systems, vehicle handling, heat transfer analysis,
etc. Most of its basic elements are defined from FORTRAN, however the latest
version is a fusion of various other languages like C++, JAVA, etc., which supports
enhanced graphical user interface (GUI) and displays. The algorithm used for
integration is the Runge-Kutta-Fehlberg algorithm with fixed order and variable step.
The algorithm evaluates the derivative three times per step and makes a second order
advance. If any error in a state is larger than that allowed, the step size is reduced
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until the error criteria are satisfied for all the states. Apart from the integration
algorithm which is built-in in ACSL, other algorithms are developed as macros and
called to solve certain simultaneous algebraic equations which are discussed in
section 3.8 of chapter 3.
In general models have several parameters to be estimated and the values for
these parameters are either taken from the literature available or they are estimated.
When available, subject-specific values of model parameters were obtained from the
literature or directly from the investigators. Usually, the age, weight, and height of a
subject were available, and often one or more additional parameters, such as Hb
concentration, total blood volume, cardiac output (Q˙), or ventilation, were provided
by the investigators. In some cases, average values for a group of subjects were used.
Predictive formulas were used to estimate Q˙ (when it was not measured) and tissue
volume of skeletal muscle ( Vm ) as functions of body weight (BW), age (A), height
(HT), and gender (G; has a value of 1 for a male and 0 for a female subject).
Predictive formulas were used from published papers,
Q ⋅ = (54.1 + 7.9G ) BW + 1400 − 200G (40)
Cardiac output was calculated in ml/min

Vm = 1000(0.244 BW + 7.80 HT + 6.6G − 0.098 A − 3.3) / 1.04 (41)
Tissue volume of skeletal muscle was calculated in ml.
2.4 Anatomy of the Heart
The heart is the mechanical pump that circulates blood through the blood
vessels involuntarily maintaining the homeostasis of blood to tissue exchange. The
heart has several surfaces (anterior, inferior) and membranes that surround and
protect the heart without interrupting the contraction and vigorous movement of heart.
The heart wall consists of three layers namely the epicardium which is the external
layer, the myocardium which is the middle layer of the wall and the endocardium, the
inner layer of the heart wall. The myocardium is an involuntary cardiac muscle tissue
which makes up the bulk of the heart and is responsible for the pumping action of the
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heart. There exists oxygen supply and consumption heterogeneity in theses layers of
the

heart

wall

corresponding

to

variable

oxygen

tensions

(Table

2.5).

The heart has four chambers. The right and left atria which receive blood from the
great veins (superior vena cava, inferior vena cava, coronary sinus) and from the
lungs through the pulmonary veins, respectively. The right and left ventricles perform
the pumping action of blood. However, these chambers also vary in thickness
according to their function. The left ventricle pumps blood to vasculature at greater
distances with large blood flow resistance resulting in higher pressures compared to
the right ventricle. Thus the left ventricle has a thicker wall as it works harder. The
left heart is generally considered the energy source of the system. The greater work
load in the left ventricle results in higher blood flow through the cardiac muscle and
greater oxygen consumption compared to other chambers of the heart, as the tissues
match their vascular function to their metabolic needs. During resting conditions, the
myocardial oxygen extraction fraction is 60-70% (42).
It is a known fact that the heart requires energy to maintain ionic balance and
synchronous contractions. This energy is supplied by the ATP (Adenosine Tri
Phosphate), which needs oxygen for aerobic metabolism to take place. In cases of
increased myocardial stress, conditions of hypoxia, hypoxemia or CO poisoning, the
energy metabolism cycles are disrupted (43-47) and an increase in coronary supply
should occur to prevent tissue hypoxia. Thus, modeling O2 delivery and demand is
needed to estimate the burden of hypoxia on the cardiac tissue. As CO impairs
oxygen delivery, causing discrepancies in the tissue-blood PO2 gradients, the
objective was to develop a model to estimate the oxygen tension in the cardiac tissue
and also predict the burden of the CO load delivered to the heart.
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Table 2.1: Myocardial Blood Flow

Species

Baboons

Condition

Region

Awake, Sitting

Left
ventricle

Left
ventricle

2.41 ±
0.90
ml/min/g
(80%)
1.74 ± 0.73
ml/min/g
(16%)
0.96 ± 0.11
ml/min/g

Right
ventricle

0.77 ± 0.07
ml/min/g

Right
ventricle
Dogs

Sedated Responsive

Dogs

Anesthetized

Dogs

anesthetized

Dogclosed
chest
Humans
25 ± 3 yr
Humans
46±12 yr

Value
(ml/min/g)

Interventri
cular
septum
Left
ventricle
Right
ventricle
Left
ventricle
Right
ventricle

Technique

Reference

15 um Microspheres

55

Microspheres

56

Microspheres

57

Microspheres

58

Microspheres

59

PET - semi-supine

60

PET

61

0.91 ± 0.10
ml/min/g
1.14 ± 0.38
ml/min/g
0.72 ± 0.28
ml/min/g
0.86
ml/min/g
0.48
ml/min/g

anesthetized

Left
ventricle

1.0
ml/min/g

[LV=196 ± 38
g]
[LV=193 ± 20
g]

Left
ventricle
Left
ventricle

0.79
ml/min/g
0.88 ± 0.19
ml/min/g

(Table also referred in Section 3.4)
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Table 2.2: Myocardial Oxygen Consumption

Species

Region

Value
(ml/min/100g)

Technique

Reference

Awake Dog

Right ventricle

4.7 ± 0.5

BNII nephelometer

51

Dog

Right atrium

4

,,

52

Dog

Left ventricle

8.6

,,

52

Dog

Left atrium

0.8

,,

52

Dog

Whole heart

8.2 ± 2.1

PET

53

Dog

Whole heart

7.0 ± 1.5

PET

Dog

Left ventricle

8.8 ± 1.5

PET

Human

Heart

8.2+/-2.1 ml/min/100g

11C-acetate and PET

(Table also referred in Section 3.4)
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54

53

Table 2.3: Skeletal Muscle Blood Flow

Values(
ml/min/100ml tissue)

Species

Region

1.4±0.6

Human

Gastrocnemius

133Xe clearance
technique

62

1.6±0.4

Human

Brachioradialis

133Xe clearance
technique

"

1.8±0.7

Human

Flexor digitorum
superficialis

133Xe clearance
technique

"

1.5±0.6

Human

Biceps

133Xe clearance
technique

"

1.6±0.4

Human

Triceps

133Xe clearance
technique

"

1.4±0.6

Human

Tibialis

133Xe clearance
technique

"

1.6±0.6

Human

Quadriceps

133Xe clearance
technique

"

2± 0.5

Human

Leg proximal

24

Method

auto radiographic

Reference

50

Table
Table 2.3
2.3 Skeletal
Skeletal Muscle
Muscle Blood
Blood Flow
Flow (Continued)
(Continued)

Values(
ml/min/100ml
tissue)
Values(
ml/min/100ml tissue)

Species
Species

Region
Region

3.1±1.7

Human

Muscle

Forearm extensor
Leg proximal

Method
Method

Reference
Reference

emission tomography
and 15 O labelled water

63

strain gauge
plethysmography and
133Xe
autoclearance
radiographic
technique
method

1.8±0.7
1.9± 0.5

Human
Human

1.9± 0.5
2.7±0.3

Human
Human

Leg middle
Forearm

auto radiographic
strain
gauge
method
plethysmography

"
"

1.6± 0.4
3±0.7

Human
Human

Leg distal
Calf

auto radiographic
strain
gauge
method
plethysmography

"
"

1.4± 0.3

Human

Leg distal

3.8±0.4

Human

Forearm

"

1.4± 0.64

Human

Brachiradialis

auto radiographic
method
venous occlusion
plethysmography and
mercury-in-silastic
strain gauges
NIRS technique after
venous occlusion

2.1± 1.1

Human

(15)) H20 PET

67

0.81± 0.47

Human

Calf - extensors
Flexor digitorum
superficialis

NIRS IO50

64

2.1± 1.1

Human

Calf - flexors

"

0.72± 0.32

Human

Flexor digitorum
superficialis

NIRS IO36

25

"
50

49

"
"

Table 2.3 Skeletal Muscle Blood Flow (Continued)

Values(
ml/min/100ml tissue)

Species

Region

Method

Reference

1.42± 1.04

Human

Brachioradialis

Fick/plethysmography

64

2.06± 0.7

Human

Forearm

"

"

2.6± 1.2

Human

Calf-profound
flexors

"

3.1± 0.27

Human

Forearm

venous occlusion and
strain gauge
plethysmography

65

3.12±1.55

Human

Femoral

(15O)H2O and PET

"

3±2

Human

Skeletal muscle

(15O)H2O,(15O)CO
and PET

66

(Table also referred in Section 3.1, Section 3.2.2)
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Table 2.4: Skeletal Muscle Oxygen Consumption

Species

Region

MRO2 Value
(ml/min/100g)

Technique

Reference

Human

Forearm

0.15 ± 0.01

NIRS -arterial
occlusion

48

Human

Forearm

0.114 ±
0.03

NIRS -venous
occlusion

49

Human

Quadriceps
femoris

0.21 ± 0.04

PET

50

Human

Quadriceps
femoris

0.21 ± 0.03
mid

PET

50

Human

Quadriceps
femoris

0.17 ± 0.02
most distal

PET

50

(Table also referred in Section 3.2, Section 3.2.2)
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Table 2.5: Myocardial Tissue Oxygen Tension in Various Species

Species

Mice(N=5)

Cat(N=6)

Cat(N=6)

Cat(N=6)

Cat(N=6)

Mouse (N=7)

Dog (N=24)

Dog (N=5)

Dog (N=12)

Dog (N=9)

Region

Left ventricle
mid-myocardium
Surface of
beating heart
(histogram) (~ 5
- 60 Torr)
Surface of
beating heart
(histogram) (~ 5
- 125 Torr)
Surface of
beating heart
(histogram) ( ~
10 - 115 Torr)
Surface of
beating heart
(histogram) ( ~ 0
- 15 Torr)

Midmyocardium

Left ventricle 6
mm deep
Anterior wall of
left ventricle
Left epicardium
(2 mm deep)
"coronary
stenosis"
Left ventricular
myocardium:
shallow - before
bypass

Mean PO2
Value

Arterial
PO2

Mean PO2 =
~15.5 mm Hg

Method

Reference

OxySpin - EPR

145

Median PO2 =
31 mm Hg

"Steady state"
(normoxia)

Platinum
electrode 8 mm

146

464.7 mm Hg

Platinum
electrode 8 mm

146

42 mm Hg

259.3 mm Hg

Platinum
electrode 8 mm

146

35 mm Hg

4 mm Hg (79%
= 0-5 Torr)

18.7 mm Hg

Platinum
electrode 8 mm

146

LiPc crystals EPR

147

Paratrend probe

147

Polarographic
Clark type

148

16.4 ± 0.7 mm
Hg

42±7 mm Hg

(normoxia)

143 ± 23

36±8 mm Hg

52±7 mm Hg

Ventilated with
100% O2 to
maintain
normocapnia

17.1 mm Hg

65 mm Hg

Monopolar
Polarographic
needle

149

150
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Mass spec

Table 2.5 Myocardial tissue Oxygen tension in various species (Continued)

Species

Dog (N=9)

Dog (N=9)

Dog (N=12)

Pig (N=13)

Region
Left ventricular
myocardium:
deep - before
bypass
Left ventricular
myocardium:
shallow - after
bypass
Left ventricular
myocardium: 3
mm deep subepicardium
Left ventricle
(surface of
epicardium)

Mean PO2
Value

Arterial
PO2

Method

65 mm Hg

Mass spec

Reference

150
14.5 mm Hg

150
28.3 mm Hg

29.5 ± 2.5 mm
Hg

65 mm Hg

Coronary
blood flow in
LAD=29.7 ±
3.9 ml/min

Mass spec

151
polarography

49 ± 2 mm Hg

23 ± 1 mm Hg

Clark-type
electrodes

151

152

Human M
38yr

Right ventricular
myocardium: 6
mm deep

39.73 mm Hg;
(median=28)

168-210 mm
Hg

Platinum needle
electrode

Human M
42yr

Left ventricular
myocardium: 6
mm deep

19.4 mm Hg;
(median=17)

78-126 mm Hg

Platinum needle
electrode

152

Human F 8yr

Left ventricular
myocardium: 6
mm deep

27.4 mm Hg;
(median=24)

48-51

Platinum needle
electrode

152

42 mm Hg
(n=15)

93 to 470 mm
Hg

mass spec

16.8 ± 4.2 mm
Hg

106 ± 5.5 on
room air

phosphorescent
O2

Human
(N=13)

Piglets

Left ventricle mid-myocardium

Epicardial
surface of left
ventricle

29

153

153

CO is exhaled through the
lungs

CO enters through the lungs

Q• v

Figure 2.1: Primary Model. The model consists of five major compartments. Mass
balance equations were written for CO. CO enters through the lungs and diffuses to
the muscle tissue and non-muscle tissue compartments via the arterial blood
compartment. CO then enters the venous blood compartments after a time delay. For
the detailed figure refer to 35
(Figure also referred in Section 3.1)

30

Continuum theory
of conservation of mass
Model Diagram and Parameter Estimation
Dynamic Equations
Computer code

Algorithms for solving
dynamic equations

SoftwareACSL

Figure 2.2: Basic Concepts of Building a Model. The basic concepts for building a
model are determining the principle for the model (conservation of mass), sketching
the model diagram, determining the parameters, and choosing suitable software to
build the model.
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CHAPTER 3
Model Description
Chapter 3 discusses a brief overview of the modifications to the primary model.
The chapter explains the general form of the mass balance equations for O2 and CO
for a model with two subcompartments. After a brief description of the cardiac
compartment of the model, the mass balance equations written for O2 and CO for
each blood and cardiac tissue subcompartment are explained in detail. Parameter
estimation for the cardiac compartment and development of predictive equations are
also discussed in this chapter. Predictive equations are developed for: (i) estimating
the volumes of muscular regions (arms, legs and trunk) for males and females (ii)
percent increase in cardiac output and heart rate as functions of increased HbCO
levels in the blood, (iii) cardiac output and heart rate as functions of total body
oxygen consumption, (iv) percent increase in heart rate as a function of increased

HbCO levels in the blood. Estimation equations were also developed for: (v)
myocardial oxygen consumption, and (vi) myocardial blood flow, both as functions
of heart rate. Sensitivity analysis is performed and parameters that influence the
oxygen tension in the myocardial tissue and vascular PO2 are determined. This
chapter also explains the validation protocol for the cardiac compartment of the whole
body model where predicted data are compared with experimental values (from
humans and animals during conditions of normoxia, hypoxia, exercise and
hyperoxia).
3.1 Overview of Desired Model
In our lab, the initial model (referred to as the primary model in this thesis,
Figure 2.1) developed by Dr. Bruce (2003) was modified to produce a second model
(referred to as the modified model in this thesis, Figure 3.1), which accounts for mass
balance of oxygen (Bruce, Bruce, and Erupaka, manuscript in preparation).
Additions in this model include O2 mass balance equations, an algorithm to calculate

PO2 corresponding to the concentration of oxygen halfway between the inlet and
outlet of the vascular subcompartment of a tissue, and a regression equation to predict
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the associated increase in cardiac output due to an increase in COHb level in the
blood. Also, skeletal muscle mass was distributed into volumes of muscular regions
(arms, legs and trunk) for males and females to account for regional heterogeneities in
muscle blood flow (Table 2.3) and O2 consumption (Table 2.4). The physiological
phenomenon of arterio-venous shunting was implemented in the lungs. Later, in an
enhancement of the modified model, a two subcompartment cardiac compartment
was added (referred to as the final model in this thesis, Figure 3.2). Development of
this cardiac compartment in the model is the first main goal of this thesis.
The skeletal and cardiac muscles exhibit major differences in morphology,
blood flow and O2 demand. Also, cardiac muscle works constantly to pump blood
unlike the skeletal muscle, and it would be inappropriate to lump the cardiac muscle
with the resting skeletal muscle. In the process of building the cardiac compartment
various other prediction equations were developed to estimate parameters needed for
the model. Parameters like myocardial O2 consumption and myocardial blood flow
were predicted as functions of heart rate; cardiac output and heart rate were calculated
from body oxygen consumption when values for heart rate and cardiac output were
not available. Also, increase in heart rate was predicted as a function of increased

COHb levels in blood.
3.2 Modified Model
The modified model consists of five major compartments: 1.The arterial blood,
2. The Lungs, 3. Skeletal Muscle with two subcompartments, 4. Non-muscle tissue
and 5. Mixed venous blood compartments (Figure 3.1). Mass balance equations are
written for oxygen (O2) and carbon monoxide (CO) for each of these compartments to
model whole body uptake of, and distribution of, CO and O2. Section 3.2.1, explains
the mass balance equation of O2 for the alveolar compartment, and Sections 3.2.2 and
3.2.3 introduce the general form of mass balance equations of O2 and CO for the
vascular and tissue compartments of the modified model.
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3.2.1 Mass Balance Equations for the Alveolar Compartment
The O2 mass balance equation for the alveolar compartment was added to the
model as follows,

VL

V.
dC A O2 (t )
= [ Pi O2 (t ) − PA O2 (t )] A − O2 flux LB
PB
dt

where, VL is lung volume, CAO2 is the alveolar O2 concentration, PAO2 is the
alveolar partial pressure of oxygen , PiO2 is inhaled PO2, t is time, V A. is alveolar
ventilation, PB is barometric pressure, and O2 flux LB (t ) is the oxygen flux from lungs
to blood, defined as
O2 flux LB (t ) = Q . (1 − SF )[C ep O2 (t ) − C mx O2 (t )] .

Where Q. is the cardiac output and SF is the shunt fraction, the percentage of
pulmonary blood flow that passes from the right to left heart without undergoing
oxygenation by the lung. CepO2 (t) is the end pulmonary oxygen concentration and

CmxO2 (t) is the oxygen concentration in the mixed venous compartment. It is
assumed that the end pulmonary partial pressure of oxygen (PepO2) equals alveolar
partial pressure of oxygen (PAO2). CO mass balance equations for the alveolar
compartment are used from the primary model which was discussed in Section 2.1 of
chapter 2.
3.2.2 Mass Balance Equations for Blood Compartments
The mass balance equations for O2 in the arterial, mixed venous and vascular
subcompartments of the skeletal muscle tissue are each described by an equation of
the general form
Vi

dC i O 2 (t )
= [C iin (t ) − C i O 2 (t )].Qi. − O 2 Flux i (t )
dt

where i is the index representing the arterial (ar), mixed venous (mx), skeletal
muscle (subcompartment m1 or m2), or venous (v) compartments. Vi is volume of
the compartment i, C iin is the concentration of O2 in blood entering the compartment
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i, C i O2 is the total concentration of O2 in the blood compartment i, and Fluxi is the
rate of diffusion of O2 out of the vascular compartment i. (Mass balance equations of

O2 and CO for individual cardiac compartments are discussed in Section 3.3 of this
chapter.)
The flux is zero for the arterial and venous blood compartments. For the nonmuscle (other) - tissues (ot) blood compartment, the Fluxot (t ) is defined as

O2 Fluxot (t ) = [ Pbot O2 (t ) − Pot O2 (t )].Dot O2
where, Pbot O2 (t ) is the mean partial pressure of O2 in the arterial inflow and
venous outflow of the non-muscle vascular compartment. Pot O2 (t ) is the partial
pressure of O2 in the non-muscle tissue compartment. Dot O2 , is the blood to tissue
diffusion coefficient of oxygen. The non-muscle soft tissue in the model is a single
compartment. Because it does not contain Mb, its uptake of CO is very small.
For the skeletal muscle (m) blood subcompartments, the general form of the
equation for Flux mj (t ) is as follows:

[

(

O2 Flux m ( j =1, 2,3) (t ) = G sf ( Pb mjO2 ) ⋅ Db mj O2 ⋅ Pb mj O2 (t ) − Pm1( or ) m 2 O2 (t )

)]

⎡ ⎛ P ⎞3 ⎤
⎟ ⎥
⎢ ⎜
PS m ∗ SO2 ∗ Vm1( or ) m 2
1500 ⎠ ⎥
⎝
⎢
D
O
and
=
G sf ( P) = 1 −
b
2
mj
⎢ ⎛ P ⎞3 ⎥
1.04
1
+
⎢ ⎜
⎟ ⎥
⎣⎢ ⎝ 1500 ⎠ ⎦⎥

where j is the index of the blood vascular subcompartments j =1,2,3 for blood
subcompartments 1 ,2 and 3, respectively. Db mj O2 is the blood to muscle tissue
diffusion coefficient. Pb mj O2 (t ) is the partial pressure of O2 corresponding to the
concentration of oxygen halfway between the inlet and outlet of the vascular
subcompartment of the skeletal muscle. Pm1O2 (t ) and Pm 2 O2 (t ) are the two
subcompartment (m1, m2) tissue O2 tensions. Vm1 and Vm 2 are the volumes of the
muscle tissue subcompartment 1 and 2, respectively. SO2 is the solubility of oxygen
in plasma and PSm is the permeability surface area product of the skeletal muscle.
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Gsf(P) is a heuristic “gain” whose only purpose is to reduce the diffusion coefficient
in hyperbaric O2 (which is not considered in this thesis). During hyperbaric O2,
hemoglobin is completely saturated with O2 and dissolved O2 concentrations increase,
thereby resulting in a decrease of the effective diffusion coefficient of O2. Gsf = 1 for
all simulations herein. The diffusion coefficient of O2 is directly proportional to
permeability surface area product. Greater permeability of the membrane for O2
means that the diffusion coefficient of O2 from blood is greater and efficiency of O2
transport from blood to tissue is greater. O2 flux depends on the pressure gradient and
the diffusion coefficient, Dbm(j=1,2,3)O2.
The total concentration of O2 in the blood compartment, C ( j =1, 2,3) O2 (t ) , is
calculated from dissolved and Hb-bound O2 concentration components so that
C ( j =1, 2,3) O2 (t ) = O2 Hb j (t ) + SO2 .Pj O2 (t ) ,

where O2Hb is the oxygen bound to hemoglobin, P( j=1, 2,3) O2 (t ) is the partial pressure

of O2 in the muscle blood subcompartment j.
Mass balance equations for CO in the arterial, mixed venous and non-muscle
tissue are described in reference 35. CO mass balance equations for vascular
subcompartments of the skeletal muscle are each described by an equation of the
form
Vi

dC i CO (t )
= [C iin CO (t ) − C i CO (t )]Q . i − Fluxi CO (t )
dt

where i=m1 or m2, the index representing skeletal muscle subcompartment 1
(m1), or muscle subcompartment 2 (m2). CiinCO(t ) is the concentration of CO in
blood entering the compartment i, Ci CO is the total concentration of CO in the
blood compartment i,
C i CO(t ) = COHbi (t ) + SCO.Pi CO(t )
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COFluxi is the rate of diffusion of CO out of the vascular compartment.

[

(

COFlux m ( j =1, 2,3) (t ) = Db mj CO ⋅ Pb mj CO (t ) − Pm1( or ) m 2 CO (t )

)]

Db mj CO is the blood to muscle tissue diffusion coefficient and is estimated by

fitting the model to experimental data (35). Pb mj CO (t ) is the average partial pressure
of CO of the vascular subcompartment j of the tissue. Pm1CO(t ) and Pm 2 CO(t ) are the
partial pressures of CO in the muscle tissue subcompartments 1 and 2, respectively.
CO mass balance equations for non-muscle tissue are the same as those in the primary
model.
3.2.3 Mass Balance Equations for the Tissue Compartments

The mass balance equations for O2 for the first skeletal muscle subcompartment
(m1) in the two subcompartment skeletal muscle model is
dC m1O2 (t ) Flux m1O2 (t ) Dm O2 [C m 2 O2 (t ) − C m1O2 (t )]
=
+
dt
Vm1
D xm

Second subcompartment m2:
dC m 2 O2 (t ) Flux m 2 O2 (t ) Dm O2 [C m1O2 (t ) − C m 2 O2 (t )]
=
+
dt
Vm 2
D xm

where,

DmO2 is the diffusion coefficient of O2 between the two

subcompartments (m1, m2) of the skeletal muscle tissue. C m1O2 (t ) and C m 2 O2 (t ) are
the partial pressures of O2 of the two muscle subcompartments 1 and 2. Dxm is the
intercapillary distance. The Fluxm1O2 (t ) and Flux m 2 O2 (t ) are defined as
Flux m1O2 (t ) = O2 Flux m1 (t ) + O2 Flux m3 (t ) −MRO2 m1
Flux m 2 O2 (t ) = O2 Flux m 2 (t ) −MRO2 m 2
where,
O2 Flux m1 (t ) , O2 Fluxm 2 (t ) and O2 Fluxm 3 (t ) are the O2 diffusion rates of
vascular blood compartments 1, 2 and 3, respectively. MRO2m1 and MRO2m2 are the
O2 metabolic rates of the tissue subcompartments 1 and 2, respectively. O2 diffuses
from the vascular to the extra vascular compartments based on the pressure gradient
between the compartments and the blood-to-tissue diffusion coefficients.
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The CO mass balance equation for the two compartment tissue model is
First subcompartment m1:
dC m1 CO(t ) Flux m1 CO(t ) D m CO[C m 2 CO(t ) − C m1 CO(t )]
=
+
dt
V m1
D xm

Second subcompartment m2:
dC m 2 CO(t ) Flux m 2 CO(t ) Dm CO[C m1CO(t ) − C m 2 CO(t )]
=
+
dt
Vm 2
D xm

where, the subscripts and parameters are the same as those above, except, DmCO
is the diffusion coefficient of CO within the two subcompartments of the tissue.
C m1CO(t )

and

C m 2 CO(t )

are the CO concentrations of the two tissue

subcompartments 1 and 2, respectively. Fluxm1CO(t ) and Flux m 2 CO (t ) are defined
as
Flux m1CO(t ) = COFluxm1 (t ) + COFluxm 3 (t )
Flux m 2 CO(t ) = COFluxm 2 (t )
where COFluxm1 (t ) , COFluxm 2 (t ) and COFluxm 3 (t ) are defined in the blood
compartments. The only difference between the mass balance equations for CO and
O2 is that oxygen is metabolized to meet the tissue metabolic demand while CO is not
metabolized.
3.2.4

Prediction equations in modified model:

Predictive equations were developed as part of this thesis and added into the
model to account for the blood flow and metabolic O2 demand heterogeneities in the
skeletal muscle tissue. Also there is an observed increase in cardiac output during CO
exposure (68,69,70). Regulation of cardiac output in response to blood HbCO levels
has been implemented into the model.
Prediction equations to estimate the volumes of regions (arms, legs and trunk
for males and females) of skeletal muscle model: Muscle metabolic rate (MRO2m) is
reported to be 20% (88, 89) of the total body oxygen consumption (MRO2) during
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rest. The metabolic rates of O2 for leg, arm and trunk muscles are different (Table
2.4). Also the blood flows to different regions of the skeletal muscle vary (Table
2.3). Thus, to incorporate these heterogeneities (different metabolic rates and blood
flows) of muscle in various regions, the skeletal mass is distributed into three muscle
volume compartments namely leg muscle volume, arm muscle volume, and trunk
muscle volume. The derivation of the equation is detailed in the appendix. The
equations (Table 3.1) for calculating the masses of trunk, leg and arm muscle are
functions of total skeletal muscle mass, Vm (41).
Tabulated blood flows and O2 consumptions for skeletal muscle tissues are
shown in table (Table 2.3 and Table 2.4) of the chapter 2. So after estimating the
volumes of the skeletal muscle regions, average values (Table 3.2) for blood flow and
oxygen consumption were determined for the muscular regions (arms, legs and
trunk). From the Table 2.2 and Table 2.3, blood flow and oxygen consumption
heterogeneity within the submuscular regions of arm (biceps, triceps, brachioradialis
etc) and leg (gastrocnemius, biceps femoris etc) muscular regions can be clearly seen.
Thus to determine the blood flow (or oxygen consumption) for the muscular regions
(arms, legs and trunk), an average of the blood flows (or oxygen consumption) from
different submuscular regions of the arm was taken. For example, to estimate the
blood flow for the arm muscular region an average of all reported blood flows ( in
ml/min/gm) for the biceps, the triceps and the brachioradialis muscles was
considered. Data for blood flow and oxygen consumption for the trunk muscles in
healthy humans has not yet been reported in the literature. Hence, blood flow and O2
consumption for the trunk muscular region was assumed to be equal to that of the leg
muscular region. Blood flow for muscles in the trunk region was reported in animals
(71, 72), but these values could not be considered due to postural differences in
humans (bipedalism) and animals (quadrupedalism). There are some constantly
working muscles in the trunk region like diaphragm (aid in breathing) which implies
that blood flow and myocardial O2 consumption must be higher than the arm
muscular region. Also the muscles in the leg region work constantly against gravity to
maintain postural balance. Since the leg and trunk muscle regions are mildly working
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skeletal muscle regions, an assumption of equal blood flow and O2 consumption was
made.
There is reported to be an increase in cardiac output and heart rate with
increase in carboxyhemoglobin levels in blood (68, 69, 70). When simulating
experiments, increased carboxyhemoglobin levels in the blood had to be taken into
account. Data for cardiac output, heart rate and carboxyhemoglobin (up to 50%) were
collected from reference 68 and 69. Linear or nonlinear regression was performed on
data, and statistical significance of the equations was tested using SYSTAT 9.0 after
outliers were eliminated. The resulting equation was tested with data (70) which were
not used in the regression. Then the equation was implemented into the model. A
detailed derivation of the equation below is discussed in appendix. Figure 3.3 shows
the data points used to build the regression relation and the relation fit developed for
predicting the increase in cardiac output as a function of blood HbCO levels, as
shown below
%ΔQ& = 0.572(%ΔHbCO)
3.3 The Cardiac Compartment

The myocardial compartment comprises three vascular subcompartments; 1, 2,
3 as shown in the Figure 3.4 and two tissue subcompartments; 1 and 2. The arterial
blood which has a partial pressure of O2, ParO2, flows into the first vascular
compartment 1, which has a blood volume of Vbcm1. O2 in blood is present in two
forms: (1) dissolved in plasma and (2) reversibly combined with hemoglobin
molecules forming oxyhemoglobin (O2Hb). Oxygen continuously diffuses into the
tissue compartment 1 as oxygen is being utilized by the tissue to meet metabolic
demand (MRO2cm1 ), causing tissue PO2 to be lower than that of the PO2 in the blood.
It is assumed that O2 diffuses from the vascular subcompartment 1 to the
extravascular subcompartment 1 of the tissues at a rate O2fluxcm1 which is based on
the oxygen diffusion coefficient Dbcm1O2 and O2 pressure gradients between the
blood and tissue. This phenomenon establishes O2 concentrations of Ccm1O2 and
Ccmv1O2 in the first tissue and blood subcompartments, respectively. In all tissue
compartments O2 bound to myoglobin is considered in addition to the prevailing O2
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concentrations. The tissue compartment 1 which has a volume Vcm1 is assumed to be
perfused by small arterioles and small venules, as well as by capillaries (Figure 3.5).
The permeability surface area product for O2 in this tissue compartment is PScm1O2.
The oxygen tension prevailing in the blood exiting from compartment 1, Pcmv1O2, is
the source for the O2 supply to the second blood compartment 2 which has a blood
volume Vbcm2. There is diffusion of O2 from the blood compartment 2 to the tissue
subcompartment 2 at rate of O2fluxcm2 with the diffusion coefficient being Dbcm2O2.
The metabolic demand of O2 (MRO2cm2), of this tissue compartment is met by
diffusion of oxygen from the vascular compartment 2 and also by diffusion from the
tissue compartment 1 with a diffusion coefficient of DcmO2. Approximately 15% of
the metabolic rate of the tissue compartment 2 is met by diffusion of O2 from its
neighboring tissue compartment 1. The tissue compartment 2, which has a volume
Vcm2, is perfused mostly by capillaries (Figure 3.5) and has a permeability surface area
product of PScm2O2. Diffusion of O2 establishes O2 concentrations of Ccm2O2 and
Ccmv2O2 in the second tissue and blood subcompartments, respectively. Now the
oxygen tension of blood exiting from the vascular subcompartment 2, Pcmv2O2 is the
O2 source for the vascular compartment 3 which has a blood volume of Vbcm3. Based
on the pressure gradients established between tissue compartment 1 and the third
blood compartment 3, there is flow of O2 at a rate of O2fluxcm3 from the tissue
compartment 1 into the blood compartment 3, resulting in an O2 concentration of
Ccmv3O2 in the third blood subcompartment. The O2 diffuses with a coefficient of
Dbvcm1O2. However, when the tissue PO2 is lower than the PO2 in the third blood
compartment then O2fluxcm3 is positive, indicating that O2 diffuses from the third
blood compartment to the tissue compartment 1. Because O2 diffusivity is similar in
plasma and muscle tissue (77), the model assumes that O2 diffusion coefficients from
blood to tissue or vice versa are equal. The concept of the two compartment model
was introduced to allow diffusion of oxygen within the tissue and also to implement
indirect arterio-venous shunting. Description of cardiac variables are summarized in
Table 3.3.
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3.3.1 Mass Balance Equation of the Cardiac Vascular Blood Compartments:

The equations below are the mass balance equations for the three vascular blood
compartments,
Cardiac vascular blood compartment 1:
Mass balance equations for O2

Vcm1

dCcmv1O2 (t )
.
= [CarO 2(t ) − Ccmv1O2 (t )]Qcm
− O 2 Flux cm1 (t )
dt

O 2 Fluxcm1(t ) = G sf ( PaacmO 2) ⋅ [Dbcm1O2 ⋅ (Paacm O2 (t ) − Pcm1O2 (t ) )]
Dbcm1O2 =

PScmav ∗ SO2 ∗ Vcm1
1.04

Mass balance equations for CO

Vcm1

dCcmv1CO(t )
.
= [CarCO(t ) − Ccmv1CO(t )].Qcm
− COFlux cm1 (t )
dt
COFluxcm1(t ) = [Dbcm1CO ⋅ (Pbcm1CO(t ) − Pcm1CO(t ) )]
Pbcm1CO(t ) = 0.5(ParCO + Pcmv1CO)
⎛ Dbcm1O2 ⎞
Dbcm1CO = DMCO1.⎜
⎟
⎝ DbM1O2 ⎠
⎛ Db M 1O2 ⎞
⎟⎟
DMCO1 = DM CO.⎜⎜
⎝ Db M 2O2 ⎠

where, Paacm is the partial pressure of O2 corresponding to the concentration of
oxygen halfway between the arterial (inlet) and vascular subcompartment 1 (outlet).
Paacm is determined by an algorithm using a gradient search technique, where the
average O2 concentration is calculated and then the PO2 corresponding to the average

O2 concentration is determined using the oxyhemoglobin saturation curve. Pbcm1, is
the average partial pressure of CO in the blood vascular subcompartment 1. Dbcm1CO
is the blood to tissue CO diffusion coefficient, DMCO1 is the blood to muscle
diffusion coefficient of CO in blood compartment 1 and Dbcm1O2 is the blood to
tissue oxygen diffusion coefficients of cardiac blood compartment 1. DbM1O2,
DbM2O2 and DMCO are blood to tissue O2 and CO diffusion coefficients of muscle
blood compartments described in Section 3.2. All other variables are defined
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in Table 3.3.
Cardiac vascular blood compartment 2:
Mass balance equations for O2
Vcm 2

dCcmv 2O 2 (t )
.
= [Ccmv1O 2(t ) − Ccmv 2O 2 (t )].Qcm
− O 2 Flux cm 2 (t )
dt

O 2 Fluxcm 2(t ) = G sf ( PbbcmO2 ) ⋅ [Dbcm 2 O2 ⋅ (Pbbcm O2 (t ) − Pcm 2O2 (t ) )]
Dbcm 2 O2 =

PScmcap ∗ SO2 ∗ Vcm 2
1.04

Mass balance equations for CO

Vcm 2

dCcmv 2CO (t )
= [Ccmv1CO (t ) − Ccmv 2CO(t )].Qcm − COFluxcm 2 (t )
dt

COFluxcm 2(t ) = [Dbcm 2 CO ⋅ (Pbcm 2 CO (t ) − Pcm 2CO(t ) )]
Pbcm 2 CO (t ) = 0.5(Pcmv1CO + Pcmv2CO)
Dbcm 2 CO = D M CO * (Dbcm2O2/Db M 2 O 2 )
Where Pbbcm is the partial pressure of O2 corresponding to the concentration of
oxygen halfway between the inlet (Pcmv1O2) and outlet (Pcmv2O2) of vascular
subcompartment 2. Dbcm2O2 is the blood to tissue diffusion coefficient. Pbcm2 is the
average partial pressures of CO in the blood vascular subcompartment 2. Dbcm2CO is
the blood to tissue diffusion coefficient, DMCO is the blood to muscle diffusion
coefficient of CO in blood compartment 2 and Dbcm2O2 and Dbm2O2 are blood to
tissue oxygen diffusion coefficients of cardiac and muscle blood compartment 2. All
other variables are define in Table 3.3
Cardiac vascular blood compartment 3:
Mass balance equations for O2
Vcm1

dCcmv3O2 (t )
.
= [Ccmv 2O 2(t ) − Ccmv3O2 (t )].Qcm
− O 2 Flux cm3 (t )
dt
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O 2 Fluxcm3(t ) = G sf ( PcccmO2 ) ⋅ [Dbvcm1O2 ⋅ (Pcccm O2 (t ) − Pcm1O2 (t ) )]
Dbvcm1O2 = Dbcm1O2 * Dbvcm _ on
Mass balance equations for CO

Vcm1

dCcmv3CO (t )
.
= [Ccmv 2CO(t ) − Ccmv 3CO(t )]Qcm
− COFluxcm3 (t )
dt

COFluxcm3(t ) = [Dbvcm1CO ⋅ (Pbcm3CO (t ) − Pcm1CO(t ) )]
Pbcm 2 CO (t ) = 0.5(Pcmv2CO + Pcmv2CO)
⎛ Dbvcm1O2 ⎞
Dbvcm1CO = DMCO3.⎜
⎟
⎝ DbvM1O2 ⎠
⎛ Db VM 1O2 ⎞
⎟
DMCO3 = DM CO.⎜⎜
⎟
⎝ Db M 2 O2 ⎠

where Pcccm is the partial pressure of O2 corresponding to the concentration of oxygen
halfway between the inlet (Pcmv2O2) and outlet (Pcmv3O2) of vascular subcompartment
3. Dbvcm1O2 is the tissue to blood diffusion coefficient, Dbvcm_on is the fraction of
blood volume in cardiac vascular compartment 1 (Vbcm1) available for gas exchange
with (venules) cardiac vascular compartment 3 (Vbcm3). Pbcm3 is the average partial
pressure of CO in the blood vascular subcompartment 3. Dbvcm1CO is the blood to
tissue diffusion coefficient. Dbvcm1O2 is the blood to tissue oxygen diffusion
coefficient of cardiac blood compartment 3. DbvM1O2, DbM2O2 and DMCO3 are
blood to tissue O2 and CO diffusion coefficients of muscle blood compartments
described in Section 3.2. All other variables are defined in Table 3.3
The O2 concentration at the input to the mixed venous compartment is
determined by a flow-weighted summation of the concentrations of O2 in the venous
outflow from the tissue compartments. This input concentration then passes through
the mixed venous compartment and returns to the lungs after a time delay. Thus the
O2 concentration at the input to the mixed venous compartment is
CVO2 (t ) = [C vot O2 (t ).(

.
Qot.
Qm.
Qcm
C
O
t
C
O
t
)]
+
[
(
).(
)]
+
[
(
).(
)] .
vm 2
vcm 2
Q.
Q.
Q.
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Where,
C vot O2 (t ) , C m O2 (t ) , C cm O2 (t ) are the O2 concentrations in the non-muscle,
.
skeletal muscle, and cardiac muscle tissues, respectively. Qot. , Qm. , Qcm
are the blood

flows to the non-muscle, skeletal muscle, and cardiac muscle tissue compartments,
respectively.
3.3.2 Mass balance equation of the cardiac tissue subcompartments :

First cardiac tissue subcompartment:
The mass balance equation for O2 in the first tissue subcompartment is
dC cm1O2 (t ) Flux cm1O2 (t ) DcmO2 [C cm 2 O2 (t ) − C cm1O2 (t )]
=
+
dt
Vcm1
D xcm

where Fluxcm1O 2(t ) is defined as
Fluxcm1O 2(t ) = O 2 Fluxcm1(t ) + O 2 Fluxcm3(t ) −MRO2 cm1

C cm1O2 (t ), C cm 2 O2 (t ) are the total O2 concentrations in the first and second
tissue compartments, Pbcm1O2 (t ) and Pbcm 2 O2 (t ) are the partial pressures of O2 of the
two tissue subcompartments. O2Fluxcm1 and O2Fluxcm3 are the blood O2 fluxes of
subcompartments 1 and 3 defined in Section 3.3. MRO2cm1 is the metabolic rate of O2
in the tissue compartment 1.
The mass balance equation for CO in the first tissue subcompartment is
dC cm1CO (t ) Fluxcm1CO (t ) DcmCO[C cm 2 CO (t ) − C cm1CO (t )]
=
+
dt
Vcm1
D xcm

where Fluxcm1CO(t ) is defined as
Fluxcm1CO (t ) = COFluxcm1(t ) + COFluxcm3(t )
C cm1CO (t ), C cm 2 CO(t ) are the CO concentrations in the first and second tissue
compartments. CO Fluxcm1 and CO Fluxcm3 are the rates of CO fluxes of the blood
subcompartments 1 and 3.

45

Second cardiac tissue subcompartment:
dC cm 2 O2 (t ) Flux cm 2 O2 (t ) DcmO2 .Vcm1 .[C cm 2 O2 (t ) − C cm1O2 (t )]
=
−
dt
Vcm 2
Vcm 2 .D xcm

where Fluxcm 2 O 2(t ) is defined as
Fluxcm 2O 2(t ) = O 2 Fluxcm 2(t ) −MRO2 cm 2

C cm1O2 (t ), C cm 2 O2 (t ) are the O2 concentrations in the first and second tissue
compartments, Pbcm1O2 (t ) and Pbcm 2 O2 (t ) are the partial pressures of O2 of the two
tissue subcompartments. O2Fluxcm2 is the blood O2 flux of subcompartment 2 defined
in Section 3.3. MRO2cm2 is the metabolic rate of O2 in the tissue compartment 2.
dC cm 2 CO (t ) Flux cm 2 CO (t ) DcmCO.Vcm1 .[C cm 2 CO (t ) − C cm1CO(t )]
=
−
dt
Vcm 2
Vcm 2 .D xcm

where Fluxcm 2 CO (t ) is defined as
Fluxcm 2 CO (t ) = COFluxcm 2(t )
C cm1CO (t ) and Ccm 2CO(t ) are the CO concentrations in the first and second
tissue compartments. CO Fluxcm2 is the CO flux of the blood subcompartment 2.
3.4 Parameters for the Model

Estimating parameters for a model is a crucial task. The heart muscle is similar
to exercising skeletal muscle. Constant exercise results in the heart muscle parameters
being different from the skeletal muscle. There are marked regional variations in flow
and oxygen consumption (Table 2.1, Table 2.2). Blood flow, oxygen consumption
and capillary density of per unit mass are greater in cardiac muscle than in resting
skeletal muscle. Capillary density/gm is ~8 times greater in cardiac muscle than in
skeletal muscle (39). Higher capillary density promotes efficient O2 transport from
blood to tissues and also within the tissue. Because blood flow and O2 consumption
increase with workload and as the heart is a vigorously working blood pump, it has a
higher blood flow and a vasculature designed for efficient O2 delivery to match the O2
demand. There is parameter heterogeneity (blood flow, oxygen consumption, regional
tissue oxygen tension, capillary density) within the various regions of the heart, the
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epicardium, myocardium and endocardium (Table 2.5, 73, 74, 75).

Also, the

chambers of the heart (right atrium, left atrium, left ventricle and right ventricle) and
the septa separating them have varied blood flow and oxygen consumption (Table
2.1,Table 2.2).The weight of the heart varies with age, gender and ethnicity of the
subject (76). Keeping in mind the inhomogeneity of heart muscle, parameters were
estimated from the available literature.
Nominal values for most of the parameters were obtained from the literature or
directly from the investigators whose data we simulated e. g., total body metabolic
rate, heart rate, cardiac output etc. In some cases parameters were estimated with
average values from a group of subjects or published predictive formulas in literature
e.g., volume of heart, blood volume, myocardial myoglobin concentration etc.
Parameter values were also estimated from predictive formulas described previously
in this thesis, e. g., myocardial O2 consumption, myocardial blood flow etc. There are
parameters like the permeability surface area product of the compartments, which
have a value at resting conditions but linearly increase in proportion to the blood flow
(90). There are some parameters like cardiac muscle volume fraction (Fvcm) and
fraction (Dbvcm_on) of

blood volume in the cardiac vascular compartment 1

(Vbcm1) available for gas exchange with (venules) cardiac vascular compartment 3
(Vbcm3) that represent quantities that are very difficult, or even impossible to
measure. Values of such parameters are unknown and estimates are made for these
values based on physiology. Parameters in this model are classified based on their
estimation method:
1. Physiological parameters
2. Model-derived parameters
3. Simulation parameters
3.4.1 Physiological parameters

These parameters are constants whose values can be found from the literature
or from experimental measurements available. Some physiological parameters are
body weight (BW), solubility of O2 in plasma (SO2), blood flows to a specific
compartment, etc. Most of these parameters are estimated by taking an average of
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several published values like myoglobin concentration (Table 3.4), values present in
literature like the volume of heart, fraction of blood etc or are directly obtained from
the experimental database to be simulated. The physiological parameters are listed in
Table 3.5
3.4.2 Model-derived parameters

These are the parameters whose values are estimated in the model from
predictive equations, e.g., myocardial blood flow, myocardial O2 consumption etc or
from formulas like the diffusion coefficients for O2 and CO or volumes of tissue
compartments. The model-derived parameters are listed in Table 3.6
3.4.3 Simulation parameters

These parameters are intermediate values of the model which help to establish
the simulation conditions. These parameters are used in accessory equations that are
needed for evaluating the derivative functions for numerical integration; aid in
simulating experimental conditions (e, g., TW, TZSS etc.). Simulation parameters
specific to ACSL are the time step (CINT) of the algorithm, the integration algorithm
used (IALG), TMAX etc. Simulation parameters are listed in the Table 3.7
3.5 Predictive Equations in the Model

Prediction equations for estimating model parameters were implemented into
the model either from the literature (published journals) or were developed especially
for the thesis. The following prediction equation for estimating blood volume in
humans was reported in reference 78. Thus the prediction equation for estimating
blood volume (when its value is not available) was added into the model:
Volume of blood =

70
BMI _ p / 22( HT ) 2
BMI=

bw
(HT ) 2

⎛ BMI ⎞
delta_IBW= ⎜
⎟100
⎝ 22 ⎠
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(78)

⎛ delta _ IBW
BMI_p= ⎜
100
⎝

⎞
⎟22 + 22 ,
⎠

where BMI is the body mass index, bw is the body weight and HT is the height
of the subject.
Estimation equations were developed for myocardial oxygen consumption and
myocardial blood flow as functions of heart rate, and for cardiac output and heart rate as
functions of total body metabolic rate. Data to establish values for parameters of these
equations were collected from various papers in the literature. Linear or nonlinear
regression was performed on data (different model/order of equations were checked) and
statistical significance of the equations was tested using SYSTAT 9.0 after outliers were
eliminated. The resulting equation was validated with data which was not used in the
regression. Then the equation was implemented into the model. The following prediction
equations were developed as part of this thesis to estimate values for unknown
parameters of the model.
3.5.1

Prediction Equations for Myocardial Oxygen Consumption and Blood
Flow

Myocardial oxygen supply and oxygen demand balance are very important for
the tissue to be viable. Data from various published papers (80-86) of myocardial
oxygen consumption and myocardial blood flow were tabulated. The strategy
followed for developing the prediction equation is shown in Figure 3.6. The data used
to develop the prediction equation had values obtained during rest and exercise
conditions. Most of the blood flow data for humans was from studies that used the
nitrous oxide dilution method. But the nitrous oxide method is reported to have
certain limitations (87) which tend to under-estimate the true blood flow; values
based on this method resulted in oxygen supply and demand mismatch when
implemented into the model. Thus, to predict the myocardial blood flows, data from a
published experiment (79) was used to derive the predictive formulas. The steps
described below were followed to establish the relations.
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1. Constructed regression relation for myocardial blood flow as a function of heart
rate. Data for regression relation was obtained from the reference 79. Myocardial
blood flow in their study was measured by dynamic PET (Positron Emission
Tomograph) accompanied by intravenous injection of labeled water ([15O]H2O).
Data used for deriving the relation and its fitted equation using linear regression is
shown in Figure 3.7
2. The next step was to correct the myocardial oxygen consumption data which was
calculated using FICK’s method, where oxygen consumption is measured as a
product of myocardial blood flow and Arterio –Venous oxygen differences.
Myocardial oxygen consumption data had to be corrected as the papers from
which (80-86) myocardial oxygen consumption data was available used blood
flow measurements based on the nitrous oxide method to calculate oxygen
consumption. The approach taken for correcting the myocardial oxygen
consumption is as follows:
A-V difference was calculated as ratio of myocardial oxygen consumption

(i)

and myocardial blood flow values obtained from studies using the nitrous
oxide method.
(ii)

Corrected myocardial oxygen consumption = Product of blood flow
calculated for heart rates in the nitrous oxide papers using regression relation
developed in step 1 and A-V differences (calculated in step 2(i)).

3. After the myocardial oxygen consumption values were corrected for the
differences in the methods, a non-linear curve fit was done using MATLAB to
establish myocardial oxygen consumption as a function of heart rate. Data used to
derive the relation and its fitted equation using nonlinear regression is shown in
Figure 3.8 .The relation obtained is as follows:
Myocardial Oxygen Consumption =

a-d
1 + (c/HR)b

where,
HR= heart rate,
a= 56.3217, asymptotic maximum,
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d

b= 4.8485, defines the slope of the function,
c= 122.6617, c is the value of the independent variable x at the inflection point.
d= 9.7643, asymptotic minimum.
Thus, to determine the myocardial oxygen consumption (ml/min/100gm) and
myocardial blood flow (ml/min/100gm), the following predictive formulas were
developed:
Myocardial Blood Flow (Q۠cm) = 2.18 * (HR) – 27.3
56.3217-9.7643

Myocardial Oxygen Consumption (MRO2cm) =
1

+ (122.6617/HR)

9.7643
4.8485

3.5.2 Prediction Equations for Cardiac Output

Cardiac output (Q.) was previously estimated as a function of body weight and
gender. This equation could be used only during conditions of basal rest. Since we
wanted to simulate experimental conditions of exercise where the cardiac output
increases, we developed equations to predict cardiac output as a function of total body
oxygen consumption (MRO2). Cardiac output and total body oxygen consumption
values were collected from various papers in the literature (See the appendix.). The
data were obtained at rest and various loads of exercise. The tabulated aggregated
data were fit with a 2nd-order polynomial as shown in the appendix.

Thus the

equation developed is
Q˙ =3.186+7.346xMRO2 - 0.535x (MRO2)2
3.5.3 Prediction Equations for Heart Rate

Often for the experiments we simulated, the investigators provided heart rates of
the subjects at rest. In simulation cases where heart rate data were not provided we
estimated the heart rate as function of total body oxygen consumption from the
equation below. The procedure for developing the equation is detailed in the
appendix. The heart rate parameter is used for estimating the myocardial oxygen
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consumption and myocardial blood flow which is discussed in Section 3.5.1 of this
chapter.
Heart Rate (HR) = 42.819+68.884*(MRO2)-8.26* (MRO2)2
Predicting percent increase in the heart rate (HR) as a function of percent
change of carboxyhemoglobin (% ∆COHb) levels in blood: There is reported to be an
increase in cardiac output and heart rate with increases in carboxyhemoglobin levels
in blood (68,69,70). While simulating experiments involving carbon monoxide (CO)
exposures, increased heart rate due to increased carboxyhemoglobin levels in the
blood had to be taken into account. These increases were implemented by introducing
the following equation whose derivation is discussed in the appendix.
%ΔHR = 0.012(%ΔCOHb) 2 + 0.26(%ΔCOHb)
The heart rate (HR) was increased by %∆HR respectively, calculated from the
above equations every 0.001 min of simulated time.
3.6 Sensitivity Analysis:

Sensitivity analysis is used to determine how “sensitive” a model is to changes in the
value of the parameters of the model and to changes in the structure of the model. It
surveys how a given model output depends upon its parameter values. It is an
important method for checking the quality, robustness and reliability of analyses and
for building confidence in the model by studying the uncertainties that are often
associated with parameters in models. It helps to determine the level of accuracy
needed for a parameter to make the model sufficiently useful and valid. The process
involves varying model parameters (one at a time, keeping other parameters constant)
over a reasonable range (especially when there is an uncertainty in values of the
varied parameter) and observing the relative changes in model response. If the testing
process reveals that the parameter varied has no significant effects on the model
response, then it may be possible to use an estimate rather than a value with greater
accuracy. But if the system behavior greatly changes with the varied parameter then
an accurate value should be determined for that parameter. If the value of the
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sensitive parameter is unknown in from the literature, then doing sensitivity analysis
helps to estimate deviations in model predictions with the parameter variation. Thus
sensitivity analysis was done to analyze the effect of model parameters on the model
predictions of myocardial tissue PO2 and coronary venous PO2. It was found that the
predicted myocardial tissue PO2 and coronary venous PO2 are most sensitive to
variations in the myocardial blood flow (Q•cm), myocardial oxygen consumption
(MRO2cm), permeability surface area product (PScm), and volume distribution
fraction of the tissue (FVcm). Table 3.9 shows the values of predicted myocardial
tissue PO2 and coronary venous PO2 with variations in the input parameters. In this
table myocardial O2 consumption (MRO2cm ), myocardial blood flow (Q·cm), PS
product (Pscm), AV Shunt fraction (Dbvcm_on), volume distribution (Fvcm) and,
inter capillary distance (Dxcm) were increased (and decreased) by 50% and the
response of the model predictions - i.e. tissue and blood oxygen tensions - to variation
of these parameters was tabulated (Table 3.8).
After doing the sensitivity analysis, a standard set of values for the following
parameters (PScm, Fvcm,Dbvcm_on, Dxcm), whose values were difficult to estimate
(due to unavailability of data) was determined. The values for these parameters are
shown in table 3.7. This standard set of parameters was arrived at after analyzing the
coronary physiology, vasculature density in myocardium and other experimental facts
such as the extent of hypoxia, exercise or CO exposure which did not cause
permanent injury or death of the subject. The volume of the cardiac compartment
(Vcm) is divided into two subcompartments of volume Vcm1 and Vcm2 by means of
the cardiac muscle volume fraction (Fvcm). The value for Fvcm was estimated to be
0.2 in order to make best estimates for tissue PO2.

The permeability surface area

product of O2 for cardiac muscle model was reported to be 200 ml/min/Torr/gm by
Beard and Bassinghwaite (90). When the above reported value for permeability
surface area product was used, final model predicted myocardial tissue PO2’s were
very low. The best estimates for tissue PO2 predictions were obtained when the PS
for the first and second cardiac subcompartments were 180 ml/min/Torr/gm and 450
ml/min/Torr/gm, respectively. There is reported to be capillary recruitment during
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exercise in skeletal muscle (102). However, the extent of capillary recruitment in
myocardium during exercise is unknown. Increase in capillary recruitment would
increase the PS as the surface area available for oxygenation would increase. PS is
reported to increase with blood flow (90), thus in the final model PS increases with
increases in blood flow. The intercapillary distance in skeletal muscle in the modified
model is 0.1 cm. The capillary density in cardiac muscle is approximately 8 times
greater than that of the skeletal muscle (39), thus the intercapillary distance for
cardiac compartment in the final model is 0.0353 cm (0.1/√8). Fraction (Dbvcm_on)
of blood volume in cardiac vascular compartment 1 (Vbcm1) available for gas
exchange with (venules) cardiac vascular compartment 3 (Vbcm3) was estimated by
analyzing the coronary vasculature (103,104). Also from the sensitivity analysis, it
can be seen that Dbvcm_on does not have a significant impact on the model
predictions of myocardial tissue PO2 and coronary venous PO2. A value of 9.5% was
chosen for Dbvcm_on as better estimates for coronary venous PO2 and myocardial
tissue PO2 were obtained for that value.
3.7 Validation Schema for the Cardiac Compartment

The final model (Figure 3.4) was used for the simulations to test the validity of the
predicted O2 related variables of the cardiac compartment. Predictions from the
model were compared with published observations on human subjects and animal
data. The model was tested for conditions of normoxic rest (91,92,95,99,100),
hypoxic rest (91,92,93,98), hypoxic exercise (91) and hyperoxia (93,94,96,97,98)
with regard to its predictions of coronary venous PO2 and tissue PO2. For validation
of human data, subject morphological data like body weight, age, etc., were used
The protocol for validation of the model was as follows:
1.

Inspired levels of O2 were set equal to the experimental values. Ventilation
was adjusted to achieve the measured arterial PO2 in the steady state.

2.

Experimentally measured values for myocardial O2 consumption and
myocardial blood flow were used in the simulations.

3. Each simulation was allowed a stabilization time of 12 min (simulation time)
and the model predictions were noted after reaching steady state.
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4. The model predictions of cardiac oxygen tensions and coronary venous PO2’s
for various conditions were compared to experimental data
5. Usually, experimental tissue PO2 values were available as either mean values or
as histograms. When a mean value was published, based on the size of the
electrode used to measure PO2, it was either classified as the average first
compartment (large electrode, assuming it was close to an arteriole) or second
compartment PO2. In the case of histograms, the mean value was used to
represent the average tissue PO2. An average of the PO2 in the histogram
above the mean was considered as the first compartment oxygen tension and
an average of the PO2 in the histogram below the mean represented the second
compartment oxygen tension.
6. Other variables validated were arterial hemoglobin saturations, venous
hemoglobin saturations and capillary PO2. But very scarce experimental data
were available for validation of these variables.
The figures showing the validation of model predicted values to the
experimental measured values for oxygen tension and coronary venous PO2 are
shown in Figures 4.1- 4.3. It can be seen from the figures that the model is fairly
capable of predicting the experimental values using a standard parameter set. This set
shall be used for simulating various experimental strategies in the Results Section.
For a human subject weighing 70 kg, 1.75 m tall and 30 years old, the predicted
steady state cardiac tissue and blood oxygen tensions during normoxia (arterial PO2 =
99 Torr) are tabulated in Table 3.10
3.8 Algorithms

In order to determine the partial pressure of oxygen (PO2), partial pressure of
carbon monoxide (PCO) and O2 flux in each blood compartment of the model, it is
necessary to solve three simultaneous algebraic equations
1. Oxyhemoglobin dissociation curve (Section 2.2, chapter 2).
2. Haldane’s equation (Section 2.2, chapter 2).
3. Blood to Tissue oxygen flux equations (Section 3.1.2, chapter 3).
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The solutions for these equations were obtained by using algorithms based on
gradient search methods which were developed for the modified model. An additional
algorithm is also developed (bisection halving) to determine the PO2 corresponding to
the average O2 concentration in the blood compartment. The technique used is a
closed domain bracketing method and the root is trapped in the interval using interval
halving (bisection) method. In this algorithm, two estimates for the root (x= PO2) are
passed as arguments, which are generally the inlet (PO2max) and outlet (PO2min)
variables ( blood O2 tension, tissue O2 tension, total concentration of O2, volume of
blood or the tissue etc) of the blood vascular subcompartments. Now the root, x= PO2
lies in the interval (PO2max , PO2min). The interval is systematically reduced based
on the evaluate function decision and the error criterion, €. The algorithm for the
search technique is shown in Figure 3.9.
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Table 3.1: Prediction Equation for Estimating Volumes of Muscular Regions (Arms,

Legs and Trunk) for Males and Females
Region

Volume in Men

Volume in Women

Leg

(46.63* Vm)/100

(49.53* Vm)/100

Arm

(15.64* Vm)/100

(13.96* Vm)/100

Trunk

(37.73* Vm)/100

(36.51* Vm)/100

Table 3.2: Blood flow and Oxygen Consumption Values for Muscular Regions
Muscular

Blood Flow

Oxygen consumption

Region

(ml/min/g)

(ml/min/g)

Arm

0.021

0.0014

Leg

0.03

0.002

Trunk

0.03

0.002
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Table 3.3 : Cardiac Compartment Variables and Description
Parameter Description
.
Qcm

Blood flow to the myocardium

SO2

Solubility of oxygen in plasma

DcmO2

Diffusion coefficient of O2 between the two tissue subcompartments

Dxcm

Intercapillary distance

Dcm CO

Diffusion coefficient of CO between the two tissue subcompartments
Blood Subcompartment 1

Ccmv1O2

Concentration of O2 in the blood compartment 1

CarO2

O2 concentration of arterial blood entering the blood compartment 1

O2Fluxcm1

Rate of O2 diffusion out of the blood compartment 1

PScmav

Permeability surface area product for arterioles and venules

Dbcm1O2

Blood to tissue diffusion coefficient

Vcm1

Volume of the cardiac tissue compartment 1

Ccmv1CO

Concentration of CO in the blood compartment

CarCO

CO concentration of arterial blood entering the blood compartment 1

COFluxcm1

Rate of CO diffusion out of the blood compartment 1

ParCO

Partial pressures of CO in the arterial blood compartment

Pcmv1CO

Partial pressures of CO in the blood vascular subcompartment 1
Blood Subcompartment 2

Vcm2

Volume of the cardiac tissue compartment 2

Ccmv2O2

Concentration of O2 in the blood compartment 2

O2Fluxcm2

Rate of O2 diffusion out of the blood compartment 2

PScap

Permeability surface area product of capillaries
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Table 3.3: Cardiac Compartment Variables and Description (Continued)
Parameter Description
Ccmv2CO

Concentration of CO in the blood compartment 2

COFluxcm2

Rate of CO diffusion out of the blood compartment 2

Pcmv2CO

Partial pressures of CO in the blood vascular subcompartment 2
Blood Subcompartment 3

Ccmv3O2

Concentration of O2 in the blood compartment 3

O2Fluxcm3

Rate of O2 diffusion into the blood compartment 2

Ccmv3CO

Concentration of CO in the blood compartment 3

COFluxcm3

Rate of CO diffusion into the blood compartment 2

Pcmv3CO

Partial pressures of CO in the blood vascular subcompartments 3
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Table 3.4: Myoglobin Concentration of the Heart. Concentrations of myoglobin were

measure by BNII nephelometer technique in various regions of the human heart. The
values were reported by CJM Joost et al ( Am J Clin pathol 2001:115:770-777)

Region

Mb Value
(g/gm wet wt)

Right ventricle

1.9

Right atrium

1.0

Left ventricle

2.4

Left atrium

0.8

Left ventricle

2.4 (0.25-11.7)

Posterior wall

2.4 (0.78-4.05)

Lateral wall

2.5 (0.67-5.21)

Anterior wall

2.2 (0.38-11.7)

Septum

2.4 (0.25-3.69)
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Table 3.5: Physiological Cardiac Parameters
Parameter

Description and references

Value

DBVcm_on

Fraction of blood that allows gas exchange with
tissue compartment 1 (Section 3.6)

0.095

rho

Density of cardiac muscle (35)

1.04 (gm/cm3)

KcmO2

Michales-Menton coefficient of cardiac muscle(35)

0.2

DXcm

Intercapillary distance in cardiac muscle
(Section 3.6)

0.0353(cm)

PScm_cap

Permeability surface area product of O2 for capillaries
(Section 3.6)

450( ml/min/Torr/gm )

PScm_av

Permeability surface area product of O2 for
arterioles/venules (Section 3.6)

180( ml/min/Torr/gm )

ConcMgb

Concentration of myoglobin (Mb)
(Table 3.4)

0.0023 ( mg/g wet wt.
muscle)

Vcm

Volume of heart (L Reiner, 1959)

254(M),180(F) (gm)

Vlv

Volume of left ventricle (75)

94(M), 67(F) (gm)

Vrv

Volume of right ventricle (75)

46(M), 33(F) (gm)

Va

Volume of atria (75)

49(M), 39(F) (gm)

Viv

Volume of intra ventricular septum (75)

64(M), 49(F) (gm)

Volfraccm

Distribution fraction of blood volume to the tissue (A
Indermuhle,2006)

0.1161(ml/gm)

FVcm

Fraction of muscle volume in comp. around arteriole
and venial blood comp.(Section 3.6)

0.2
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Table 3.6: Model -Derived Parameters
Parameter

Description

Value

Vcm1

Volume of cardiac muscle in compartment 1 perfused by
arterioles/venules

FVcm.Vcm

Vcm2

Volume of cardiacmuscle in compartment 2 perfused by
capillaries

(1.-FVcm).Vcm

MRO2cm

Metabolic rate (MR) of O2 of cardiac muscle tissue

Refer Section 3.5.1

MRO2_cm1

MR of O2 of skeletal muscle tissue 1

MRO2_cm1

MR of O2 of skeletal muscle tissue 2

Qdotcm

Blood flow to the cardiac muscle tissue

MRO2cm.Vcm1/(Vcm1+Vc
m2)
MRO2cm.Vcm2/(Vcm1+Vc
m2)
2.18 . (HR) – 27.3

DcmCO

Cardiac Muscle diffusion coefficient for CO

Vbcm

Volume of blood in cardiac compartment

Volfraccm.Vcm

Vbcm1

Blood volume of cardiac blood compartment 1

(Fvcm.Vbcm) -Vbcm3

Vbcm2

Blood volume of cardiac blood compartment 2

(1.0-Fvcm).Vbcm

Vbcm3
DcmO2

Blood volume of cardiac blood compartment 3
Inter-cardiac tissue diffusion coefficient of O2

Fvcm.Vbcm .Dbvcm_on
60.DO2.10.

DcmCO
Dbcm1O2

Intercardiac tissue diffusion coefficient ofCO
Diffusion coefficient of O2 from blood compartment 1 to
cardiac tissue compartment 1;

fac.DcmO2
PScm_av.SO2.Vtm1/rho

Dbcm2O2

Diffusion coefficient of O2 from blood compartment 2 to
cardiac tissue compartment 2;

PScm_cap.SO2.Vtm2/rho

DcmCO_1

Diffusion coefficient of O2 from blood compartment 1 to
cardiac tissue compartment 2

(Dbm1O2/Dbm2O2).DcmCO

DcmCO_2

Diffusion coefficient of O2 from blood compartment 2 to
cardiac tissue compartment 2

DcmCO

DcmCO_3

Diffusion coefficient of O2 from blood compartment 2 to
cardiac tissue compartment 3

DMCO_3.(Dbvcm1o2/Dbv
m1o2)

fac

Diffusion coefficient. for CO in tissues is 75% of O2
diffusion coefficient

0.75
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DMCO.(Dbcm2O2/DbMO2)

Table 3.7: Simulation Parameters
Parameter

Description

Value

PbO2wi

Atmospheric pressure during CO exposure

Simulation specific

Pbo2wo

Atmospheric pressure during treatment

Simulation specific

TW

Time by which the model reached steady state.

12 minutes

COcm0pc

Initial %CO in cardiac compartment(cpt)

Subject specific (%)

COcvm0pc

Initial %CO in cardiac venous cpt.

Subject specific (%)

Gmix_cm

O2 mix gain of cardiac tissues

1

CINT

Time step of the integration algorithm

0.001

Tmax

Maximum time of the simulation

Simulation specific

IALG

Integration algorithm used

8(Runge kutta Fehlberg)

Tzss, Tco

Time at which CO exposure begins (or is present)
in the simulation

Simulation specific

COppm

Concentration of CO in part per million

Simulation specific

VdotWI

Ventilation at the time of CO exposure

Subject specific

VdotWO

Ventilation at the time of treatment

Subject specific
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Table 3.8: Sensitivity Analysis of the Parameters
Parameter

Variation

Tissue PO2_1

Tissue PO2_2

Venous PO2

O2 consumption

↑ 50%

↓

↓

↓

Mro2cm

↓ 50%

↑

↑

↑

Blood Flow

↑ 50%

↑

↑

↑

Q.cm

↓ 50%

↓

↓

↓

PS product

90

21.78

22.05

20.76

Pscm_av

270

44.7

20.98

20.74

PS product

225

37.97

12.711

20.86

Pscm_cap

675

39.38

24.47

20.73

AV Shunt fraction

0.0475

40.34

21.69

20.74

Dbvcm_on

0.1425

37.86

21.28

20.74

Volume distribution

0.1

49.52

23.25

20.74

fvcm

0.3

32.45

19.98

20.7

Table 3.9: Values for Standard Set
of parameters
Parameter

Value

Pscm_av

180

Pscm_cap

450

Dbvcm_on

Table 3.10: Steady State Values
in human
Parameter

Value(torr)

PCM1O2

39

0.095

PCM2O2

21.47

fvcm

0.2

PCMV1O2

50.91

Dxcm

0.0353

PCMV2O2

20.23

PCMV3O2

20.74
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Figure 3.1: Modified Model. The model consists of lungs, arterial and mixed venous

blood, non-muscle tissue and two subcompartments within the muscle tissue. (Bruce,
Bruce, Erupaka)
(Figure also referred in Section 3.2)
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Figure 3.2: Final Model. The model consists of lungs, arterial and mixed venous blood,

non-muscle tissue, two subcompartments within the muscle tissue and the cardiac
compartment with two subcompartments.
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Figure 3.3: Cardiac Output and Carboxyhemoglobin. Figure shows the plot of the data

(o) used (68,69,70) to build the relationship and the predicted data (*). The percent
increase in carboxyhemoglobin levels of blood, %∆COHb is plotted on the x-axis and
the percent increase in cardiac output, %∆Q• on the Y-axis. Test data points (o) were
considered from experiments whose data were not included in building the relation to
check with the values (o) obtained from the predictor equation.
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ParO2

Vbcm1

Pcmv1O2

1
PCM1O2
COMb1
VCM1
PScm1

Vbcm2

PCM2O2
COMb2
VCM2
PScm2

DcmCO

2
Dcm02

2

1
Pcmv3O2

Vbcm3

Pcmv2O2

3

Figure 3.4 : Two Subcompartment Cardiac Tissue. The figure shows the two cardiac

tissue compartments -1, 2 and the three cardiac blood compartments -1, 2, and 3
surrounding the cardiac tissue.

1

2

a

ca
cv

v

Figure 3.5: Vasculature of Cardiac Compartment. The tissue compartment 1 is

assumed to be perfused by small arterioles (a) and small venules (v), as well as by
capillaries The tissue compartment 2, is perfused mostly by capillaries (Ca, Cv).
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Collect HUMAN data from various journals for
1. Myocardial oxygen consumption
2. Myocardial blood flow
3 Heart Rate

Exclude data with measurement limitations like myocardial blood flow
measured using Nitrous oxide dilution method had many limitations
which tented to underestimate the myocardial blood flow prediction.

Tabulate and plot the data

Perform regression analysis

Choose statistically significant prediction and validate it for
data set not used to build the relation

Implement the relation into the model

Figure 3.6: Strategy for Developing Prediction Equations for the Model

69

Myocardial Blood Flow(Q.cm) - ml/min/100gm
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Figure 3.7: Heart Rate and Myocardial Blood Flow. Figure shows the plot of the data

(o) used to build the relationship (79) and predicted data (*).The heart rate is plotted
on the x-axis and the myocardial blood flow is plotted on the y-axis. Test data points
(o,o) were considered from experiments whose data (161) were not included in
building the relation to check with the values(*,*) obtained from the predictor
equation.
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Myocardial Oxygen Consumption-ml/min/100gm
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Figure 3.8: Heart Rate and Myocardial Oxygen Consumption. Figure shows the plot

of the data (o) used to build the relationship (80-86) and predicted data (*).The heart
rate is plotted on the x-axis and the myocardial oxygen consumption is plotted on the
y-axis. Test data points (o,o) were considered from experiments whose data was not
included in building the relation to check with the values(*,*) obtained from the
predictor equation.
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Start with interval (a=PO2max , b=PO2 min )

c = (PO2max +PO2 min)/2

Compute f(a)f(c)

<0

>0
=0

a=a
b=c
(a,c)

a=c
b=b
(c,b)

x=c

END

Compute f(a)f(c)
Continue iteration
until a-b≤ €

Figure 3.9: Flow chart for the Algorithm
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CHAPTER 4
Results
Chapter 4 presents both the validation results for the cardiac
compartment and model predictions of extravascular burden of CO, and the
resulting PO2 levels, for various simulations. This chapter describes the
simulation conditions in detail like the inputs to the model, levels of CO
exposures, time of CO exposure, type of treatment (room air or 100% O2) and
data source etc. Also in this chapter, model predictions are graphed and
tabulated for various experimental conditions that were simulated using the
developed model.
The final model (Figure 3.2) is used for validating the cardiac compartments
and for all other simulations listed below. The validation protocol for the
cardiac compartment has already been described in Section 3.7 of Chapter 3.
Predictions from the model were compared with published observations on
human subjects and animal data (Table 4.1). The model of the cardiac
compartment is validated for conditions of hypoxia, exercise and hyperoxia.
4.1 Model Validation

Model predictions for the blood and tissue PO2 were compared with
experimentally measured values from various experiments reported in the
literature (Table 4.1). These variables (myocardial tissue and blood PO2) were
evaluated for conditions of hypoxia, hyperoxia and exercise in the absence of
CO. Most of the available experimental data are from anesthetized animal
studies. Figure 4.1, Figure 4.2, and Figure 4.3 show the comparison of model
predictions (myocardial tissue and coronary venous PO2) with experimentally
measured values. From Figure 4.1 it can be seen that the model predictions
of coronary venous tend to overestimate the coronary venous PO2 when
compared to the experimental data reported in the literature. The model
estimates are ~34.7% greater than the experimentally measured coronary
venous PO2 values. Figure 4.2 shows the comparison of model predictions of
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myocardial tissue PO2 in subcompartment 1 with experimentally measured
myocardial tissue PO2 (measurement sites close to arterioles or generally a
large electrode or the average value of the upper half of PO2 histograms was
used). The model predictions of the first compartment tissue PO2 match well
with the experimentally measured values reported in the literature. However,
at lower experimental PO2 the model tends to slightly overestimate the
predicted PO2’s. In Figure 4.3, comparison of model predictions of
myocardial tissue PO2 in subcompartment 2 with experimentally measured
myocardial tissue PO2 is shown. The experimental measurement made with
electrodes whose size is comparable to that of a capillary and the average
value of the lower half of PO2 histograms was assumed to represent the tissue
PO2 in the second compartment. The predictions made by the model for
myocardial tissue PO2 of subcompartment 2 slightly underestimate the
experimentally made measurements by 28.37%. At very low experimentally
measured PO2’s, the model predicts negative tissue PO2. Values of certain
parameters like PS (permeability surface area product) and FVcm (volume
distributing fraction of cardiac compartment) were determined to best fit the
model predictions with the experimental data. Thus, model validation also
helped to determine the values (Section 3.6) for some parameters.
4.2 Model Simulations
The major goal of the thesis was to predict myocardial MbCO

levels and tissue PO2 levels (extravascular burden) during CO exposures and
treatment sessions. Estimating the extravascular burden of CO on the heart
will aid in understanding the severity of myocardial tissue hypoxia during (or
after) CO poisoning. The various simulations done below explain the data
source, experiment protocol, relevance of simulation, inputs to the model
available (provided by the investigators of the experiment), model parameters
determined, and predictions of extravascular burden of CO on heart and
coronary venous PO2 (outputs). In all the simulations extravascular
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(myocardial tissue PO2 and MbCO) burden of CO on human heart is
predicted. The following simulations have been analyzed in this thesis:
1.

Simulation of short-high concentration CO exposure.

2.

Simulation of long-low concentration CO exposure.

3.

CO rebreathing during 100% O2 administration.

4.

CO exposure during Rest and Exercise Sessions

4.2.1 Short Duration-High Concentration CO Exposure:

Data Source for the Simulation: Subject 120, Reference 154. Benignus et.al
exposed human subjects to high concentration of CO (6683 PPM) during
room air breathing for 4-6 Minutes, followed by washout on air for 4-5 hrs.
Experiment Protocol:

12min
T=0

5min

283 mins

TW TCO TRA
6683 ppm

Tend

Tw = Time for the model to reach a steady state (12 min)
TCO= Start time of CO exposure
TRA= Start time for treatment with room air
Tend = End time of simulation
Simulation Relevance: This kind of simulation would find relevance when
trapped for 5-10 mins in a house or a coal mine which is on fire, or in a car
with its exhaust blocked.
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Parameters Provided by Investigators: age, gender, height, body weight,
concentration of CO, hemoglobin concentration in blood, barometric pressure,
temperature, cardiac output , ventilation, volume of blood, exposure and
treatment times, room air treatment, HbCO levels in radial artery and
antecubital vein sampled every minute for the first 6 min, then intermittently
thereafter.
Parameters Determined: Total body O2 consumption (233 ml/min/Kg), heart
rate (Section 3.5.3), ventilation adjusted, diffusion coefficient for CO (Bruce,
Bruce and Erupaka), myocardial blood flow (Section 3.5.1), myocardial O2
consumption (Section 3.5.1), increases in cardiac output (Section 3.2.4) and
increases in heart rate (Section 3.5.3) with increases in blood HbCO levels.
These parameters are the values determined from regression relationships or
from the literature.
Model Predictions: Figure 4.4 shows the predicted HbCO levels in arterial
blood, coronary venous partial pressure of O2 (PcvO2), oxygen tension in
cardiac

subcompartment

1

(Pcm1O2),

MbCO

levels

in

cardiac

subcompartment 1 (MbCOcm1), oxygen tension in cardiac subcompartment 2
(Pcm2O2) and MbCO levels in cardiac subcompartment 2 (MbCOcm2). The
values of the predicted variables are as shown below:
Variable
% HbCO

Values before begin

Values at End of

Values at End of

of CO Exposure

CO Exposure

Treatment

0.73

14.17

6.19

%MbCOcm1,%MbCOcm2

0.25, 0.32

5.39, 7.38

2.34, 3.08

Pcm1O2, Pcm2O2(Torr)

36.52, 19.33

21.45, 13.26

36.01, 21.08

PcvO2 (Torr)

19.06

12.84

16.46
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As seen in Figure 4.4 MbCO levels in compartment 2 are higher than in
compartment 1, resulting in a lower tissue PO2 in compartment 2 after CO
exposure. The HbCO level in arterial blood increases, resulting in increased
cardiac output. Increase in cardiac output is achieved by increased myocardial O2
consumption accompanied with increase in myocardial blood flow. More CO load
is delivered to the tissues due to increase in blood flow to the tissue. Also, the
myocardial O2 consumption increases and the tissue PO2 falls resulting in higher
MbCO levels. Figure 4.5 shows comparison of the MbCO levels and tissue PO2 of
resting skeletal muscle and cardiac muscle tissues for the same CO exposure
protocol. It can be seen from the Figure 4.5 that the MbCO levels are lower and
the tissue PO2 are greater in skeletal muscle than that of cardiac muscle. Lower
MbCO levels in resting skeletal muscle are due to lower oxygen consumption,
lower blood flow, less CO load delivered and higher PO2 than that of cardiac
muscle, which is a rigorously working muscle. The values for the resting skeletal
muscle are as shown below

Variable

Values
begin

before
of

CO

Exposure
% HbCO

%MbCOcm1,%MbCOcm2
Pm1O2, Pm2O2 (Torr)

Values at End
of

CO

Values at End of
Treatment

Exposure

6.19

0.73

14.1
7

1.99, 2.05

0.39, 0.48

2.3, 1.57

42.03,

35.9, 22.16

39.16,

27.75

25.09

4.2.2 Long Duration-Low Concentration CO Exposure

Data Source for the Simulation: The same parameters used in section 4.2.1
were used for this simulation. But the experiment protocol is different for this
simulation. Subject 120 is exposed to 90 ppm of CO for a period of 8 hrs.
There is no treatment in this protocol.
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Simulation Relevance: This kind of simulation would find relevance when
there is a faulty heater at work place or a faulty furnace at home.
Experiment Protocol:

12min
T=0

480 mins

TW TCO
90 ppm

Tend

Model Predictions: Figure 4.6 shows the predicted HbCO levels, coronary
venous PO2, PcvO2, MbCO levels, MbCOcm1 and MbCOcm2 and myocardial
oxygen tensions, Pcm1O2 and Pcm2O2,. The predicted values before CO
exposure are similar to the values of the simulation above (Section 4.2.1).
Simulating this experimental protocol would help to understand the impact of
CO load on the heart for a greater length of time and its resulting effect on the
myocardial O2 tension. Concentration of CO exposure is lower in this
simulation but is present for a greater length of time. The HbCO levels in
blood reach ~9.6% resulting in MbCO levels of 3.84% and 5.24% in cardiac
subcompartments 1 and 2. The tissue PO2 in the first subcompartment is 32
Torr, which is a reasonable PO2 however, the tissue PO2 is slightly lower in
the subcompartment 2 (which is a major subcompartment of the heart model)
for a long duration of time, resulting in tissue hypoxia. If the duration of CO
exposure or concentration of CO would be increased, then the cardiac tissue
would be O2 impaired for longer duration of time resulting in imbalance of
homeostasis of O2 delivery and metabolism of heart. The values of the
predicted variables are as follows:
Variable

Values at End of CO
Exposure

% HbCO

9.5904

% MbCO

3.84, 5.24

Tissue PO2 (Torr)

32, 15.12

Cardiac Venous Po2 (Torr)

14.91

78

4.2.3 CO Rebreathing During 100% O2 Administration

Data Source for the Simulation: Subject 1, Reference 155. Burge & Skinner
had conducted CO rebreathing experiments in hyperoxia (100% O2) to
estimate the total blood volume. Subjects in this study rebreathed 60-70ml of
CO for a period of 40 mins while breathing 100% oxygen.
Simulation Relevance: This method is a standard one used for determining
total blood volume of a subject. Also, the closed breathing design of the
experiment helps in estimating the blood-to-tissue diffusion coefficient of CO
(35) because the slow decrease in %HbCO after 10 min is sensitive to this
coefficient.

Experiment Protocol:

12min
T=0

40 mins

TW ( TO2 ,TCO )

Tend

70 ml

TO2= Start time for treatment with 100% O2
Parameters Provided by Investigators: age, gender, height, body weight,
injected volume of CO, barometric pressure, temperature, volume of blood,
exposure and hyperoxia breathing times, and volume of the rebreathing
circuit.

Parameters Determined:

Total body O2 consumption (233 ml/min/kg),

cardiac output (Section 3.5.2), heart rate (Section 3.5.3), ventilation is
assumed to be 0 during rebreathing, diffusion coefficient for CO (Bruce,
Bruce and Erupaka), myocardial blood flow (Section 3.5.1), myocardial O2
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consumption (Section 3.5.1), increases in cardiac output (Section 3.2.4) and
increases in heart rate (Section 3.5.3) with increases in blood HbCO levels
The parameters during 100% oxygen breathing are not known. Regression
equations developed for determining parameters during normoxia were
applied for predicting cardiac ouput, heart rate etc., during hyperoxia.
Model Predictions: Figure 4.7 shows the predicted HbCO and MbCO levels in
arterial blood and tissue subcompartments, coronary venous partial pressure of
O2 (PcvO2) and

myocardial oxygen tensions. MbCO levels of

subcompartment 1 are greater by 2% than the subcompartment 2 during the
intial 5-6 mins of the experiment and then the MbCO levels in the two
subcompartments reach equilibrium. The tissue PO2 falls approximately by 46
Torr in the subcompartment 1 and 7 Torr in the subcompartment 2. However
after the end of CO exposure, the tissue PO2 of cm1 increases approximately
to 92 (close to value before CO exposure) Torr, and the PO2 of cm2 increases
to 20.31 Torr. However the tissue PO2 in cm2 does not increases as much as
expected during 100% O2 breathing. This could be due to errors in
determining the parameters during treatment protocol. The values of the
predicted variables are as follows:
Variable

Values before begin

Values at End of

of CO Exposure

CO Exposure

% HbCO

1.07

10.94

%MbCOcm1,%MbCOcm2

1.07, 0.92

3.96, 3.56

Pcm1O2, Pcm2O2(Torr)

96.4, 22.56

50, 17.3

PcvO2 (Torr)

23.29

17.07

4.2.4 CO Exposure During Exercise

Data Source for the Simulation: Subject 21, Reference 69. Kizakevitch
et al. conducted experiments where the subjects performed lower body
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exercise using a treadmill. Subjects underwent air exposures at their base
level HbCO (0-2%) and CO exposures to fours levels of HbCO (5%, 10%,
15%, 20%). At each level of HbCO, subjects underwent exercise sessions
comprised of rest and three 5 min exercise periods (R, E1, E2, E3). The
exercise intensity was increased in a step wise fashion and the experiment was
conducted over two days.
Simulation Relevance: Working groups exposed to CO concentrations higher
than the permissible levels are more susceptible to severe tissue hypoxia
because increased work increases the oxygen demand in the tissue, but CO
interferes with O2 delivery by binding to hemoglobin. Myoglobin
functionality is also impaired as CO binds to myoglobin, further impairing O2
availability. Predicting tissue oxygenation and MbCO levels in the cardiac
compartment during CO exposures will estimate the extent of tissue hypoxia
in the heart.
Parameters Provided by Investigators: age, gender, height, body weight,
concentration of CO in inspired air (1000 ppm for 5% HbCO, 3000 ppm for
10%, 15% and 20% HbCO levels. 27 ppm, 55ppm, 83ppm and 100 ppm were
used to maintain HbCO concentrations at 5%, 10%, 15% and 20%
respectively), total body metabolic rate, ventilation , cardiac output, heart
rate, times for begin of exercise stages and time of 100% O2 exposure.
Experiment Protocol:
The protocol the authors followed was as follows:
E = Exercise; R= Rest
Day 1: Baseline HbCO (R, E1, E2, E3) - 5% HbCO(R, E1, E2, E3) 15% HbCO – (R, E1, E2, E3)- Administer 100% O2
Day 2: Baseline HbCO (R, E1, E2, E3) - 10% HbCO(R, E1, E2, E3) - 20%
HbCO – (R, E1, E2, E3) - Administer 100% O2.
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Parameters Determined: Diffusion coefficient for CO (2.5 ml/min/Torr),
myocardial blood flow (Section 3.5.1), myocardial O2 consumption (Section
3.5.1), blood volume, ventilation adjusted to maintain normoxic arterial PO2,
cardiac output (Section 3.5.2,3.5.3) and heart rate during O2 administration .

Model Predictions:
4.2.4.1 Baseline HbCO (1.9%) at Rest and Three Levels of Exercise:

(Figure 4.8). Myocardial tissue and venous PO2 decrease from rest in a
stepwise fashion with exercise stages 1 and 2. At the beginning of exercise
stage 3, the PO2 in the myocardial tissue and blood subcompartments
increase. The MbCO levels in the subcompartments increase but are
insignificant. There is a significant decrease in tissue PO2 (decreases by 10
Torr and 6 Torr, respectively) of cm1 and cm2 at the end of exercise stage 2.
There is an increase in tissue oxygen tensions during exercise stage 3. With
increased exercise load one would expect the tissue PO2 to fall, but the tissue
PO2 increases because the cardiac output increases by 2.6 times the resting
value. Increase in cardiac output results in increased blood flow to the heart
and there is more O2 available for delivery to the tissues. Also the HbCO
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levels are minimal, resulting in noncompetitive binding of O2 with
hemoglobin, there by resulting in increased tissue PO2. The values are
Variables

Rest

Exercise 1

Exercise 2

Exercise 3

% HbCO

1.9

1.9

1.9

1.9

% MbCO

0.68, 0.87

0.73, 0.98

0.86, 1.24

0.73, 0.95

Tissue PO2 (Torr)

34.26, 18.66

28, 15.8

24.43, 12.36

32.5, 18.2

Cardiac Venous PO2

20.9 Torr

17.8 Torr

15.09 Torr

19.54 Torr

4.2.4.2 HbCO (10%) at Rest and Three Levels of Exercise (Figure 4.9)

The subcompartment MbCO levels increase with stages of exercise, though
the HbCO levels are maintained at 10%. The PO2 (tissue and blood) in the
cardiac subcompartments decrease and MbCO levels increase linearly till the
constant HbCO levels of 10% are attained. There is a negligible increase
noticed in MbCO levels during the 5 min rest period, followed by a steep
increase during exercise stages 1 and 2 and then a linear increase during
exercise stage 3.
Variables
% HbCO

Rest
9.94

Exercise1

Exercise 2

Exercise 3

10

9.97

10

% MbCO

3.76, 5.09

4.12, 5.62

4.05 , 5.51

4.8, 7.1

TissuePO2

32.03, 15.33

31.14, 14.15

31.22 , 14.17

25.15, 10.45

16.61 Torr

15.76 Torr

15.74 Torr

12.85 Torr

(Torr)
Cardiac Venous
Po2

The tissue and blood PO2’s of heart decrease by 1-2 Torr initially during the
rest session, then fall by few Torr and are maintained constant during stages 1
and 2 of exercise. There is a significant drop of PO2 in tissue and blood
subcompartments during exercise stage 3, especially in tissue subcompartment
2. The heart rate during stage 3 increases approximately by 98% due to
exercise and increase in blood HbCO levels. Increased heart rate increases
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myocardial O2 consumption and myocardial blood flow. Also the cardiac
ouput increases due to exercise and CO exposure. This results in more CO
load being delivered to the heart, as CO has more affinity than O2 to bind to
hemoglobin. It results in higher MbCO levels and lower tissue PO2 in the
subcompartments of the heart.
4.2.4.3 HbCO (20%) at Rest and Three Levels of Exercise (Figure 4.10)

The subcompartment MbCO levels increase with stages of exercise, though
the HbCO levels are maintained at 20%. After reaching constant HbCO level
of 20%, there is a step wise decrease in PO2’s (of myocardial tissue and blood
subcomparments) with exercise stages. There is a decrease of tissue and
blood PO2 in the cardiac subcompartments with linear increase of tissue
MbCO levels. There is a significant large drop in the oxygen tensions of tissue
subcompartment 2 during exercise stage 1 and exercise stage 2 compared to
exercise stage 3. The cardiac output increases by 81%, 102% and 119%
respectively compared to the rest session at 20% HbCO levels. Increasing
metabolic demand of O2 with exercise stages and poor tissue oxygenation due
to increased CO load (due to increasing blood flow) results in PO2 of 3.7 Torr
and 2.28 Torr. If these tissue PO2 persists for longer time, then the metabolic
oxygen demands may be met with anaerobic metabolism.
Variables

Rest

Exercise1

Exercise 2

Exercise 3

% HbCO

19.78

19.73

19.7

19.6

% MbCO

8.81, 12.74

11.07, 17.49

14.25, 25.25

18.75, 33.93

TissuePO2

23.8, 10.29

20.03, 6.66

14.55, 3.71

9.19, 1.92

11.91 Torr

8.8 Torr

5.6 Torr

2.28 Torr

(Torr)
Cardiac Venous
Po2
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4.2.4.4 HbCO (20%) at Rest and Three Levels of Exercise Followed with 100% O2
Treatment:

After the third stage of exercise, the subject breathed 100% O2 for 60 mins
(Figure 4.11). The model predictions at the end of 60 mins are as follows
Variables

Rest

End of therapy

% HbCO

1.9

13.78

% MbCO

0.68, 0.87

6.97, 8.38

TissuePO2 (Torr)

34.26, 18.66

108, 17

Cardiac Venous Po2

20.9 Torr

18.45 Torr

100 % O2 breathing after CO exposure decreases the HbCO and MbCO levels in
arterial blood and the cardiac tissue subcompartment (Figure 4.11). There is an
increase in myocardial blood and tissue PO2’s with 100% O2 breathing. A
significant increase in the tissue PO2 of cardiac subcompartment 1 is observed
with 100% O2 breathing. However, the PO2 of tissue subcompartment 2 only
increases to 17 Torr after 100% O2 breathing. The MbCO levels in cm2 are 8.38%
after breathing 100% O2. The cardiac output for this session (breathing 100% O2)
was determined from the predictive equation considering the total body O2
consumption at rest (during 20% HbCO). Making this assumption may have
effected the prediction for second compartment myocardial tissue PO2. The
determined cardiac output may have been underestimated for the hyperoxia
session which resulted in lower blood flow to the heart compartment. Also the
MbCO levels were higher in the second compartment accompanied with lower
blood flow during hyperoxia which resulted in lower tissue PO2 in cm2 at end of
therapy (recovery) session. Figure 4.12 compares the model predictions for
extravascular burden of CO (PO2 and MbCO) while breathing 100% O2 vs Room
air after CO exposure. It can be seen from the figure that breathing 100% O2 after
exposure shows higher tissue PO2 and lower MbCO levels than breathing room
air.
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4.2.4.5 Baseline HbCO (1.9%) - HbCO (5%) - HbCO (15%) (Each session at
Rest and Three Levels of Exercise) Followed with 100% O2 Treatment.

Figure 4.13
There is a step wise decrease in PO2’s (of myocardial tissue and blood
subcomparments) with exercise stages and increasing HbCO levels. There is an
increase in myocardial blood and tissue PO2’s with 100% O2 breathing. Also, the
HbCO and MbCO levels in arterial blood and the cardiac tissue subcompartment
decreases with 100 % O2 breathing after CO exposure. The responses of decreases
in PO2 and increases in MbCO levels (of the cardiac subcompartments) are
qualitatively similar to the exercise simulations discussed above for 10% and 20%
HbCO levels but the values reach are quantitatively different as the current
simulation involves lower HbCO levels of 5% and 15 % compared to 10% and
20%. Thus we can expect that with increasing HbCO levels, the quantitative
values attained may be different but the same qualitative response pattern may be
followed.
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Table 4.1 : Validation of the Model.
R

Species

Exp
.
Par
O2

Model
Par O2

91 Human

99

98.98954

91 Human

42

91 Human
157

Exp.
PcmvO

Model
PcmvO2

Exp.
PtO2

Model
Pcm1 O2

Model
Pcm2 O2

Q۠cm

Mr
O2c
m

17.25

20.50

-

34.84992

19.69238

118

15

43.66366

15.75

12.96

-

16.6563

13.77764

167

17

36

36.9957

15

11.45

-

13.41558

12.40324

261

25

Dog

92

91.76348

18.8

25.39

19.9

48.66612

29.18559

157

Dog

92

91.76348

26

25.39

-

48.66612

29.18559

90

6.6

45

Dog

32

32.05925

22

19.99286

-

23.1705

21.40628

160

9.79

45

Dog

27

27.79234

18

19.91647

-

21.8324

20.94568

210

6.7

96 Swine

103

103.4311

27.33

27.34

50

41.64232

27.36177

94

6.7

96 Swine

57

57.94478

22.77

30.84952

35

40.77736

33.06806

129.7
2

5.695

96 Swine

44

44.08298

19.75

27.27827

26

30.6389

27.93219

147.5
8

5.963

96 Swine

189

190.4437

31.8

24.08567

-

59.21405

27.35737

125

11.3

94 Swine

39

39.42103

21

17.97635

-

23.59683

19.52166

175

12.5

94 Swine

40

40.54051

17

20.95588

-

26.80393

22.58181

173

9.8

0.8

0.1

2

93

Dog

64.2

64.1

18.3

19.314

18.9

35.456

24.34

93

Dog

326

325.36

-

20.93615

49/26

61.77243

23.12536
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Table 4.1: Validation of the Model (Continued)
R

Species

93

Rat

Exp
.
Par
O2
99

Model
Par O2

Exp.
PcmvO

Model
PcmvO2

Exp.
PtO2

Model
Pcm1 O2

Model
Pcm2 O2

Q۠cm

mr
O2c
m

-

20.80742

40/20

42.32027

21.26861

4.5

0.54

93

Rat

89

88.34195

-

20.24898

15/35

38.95486

19.60096

4.5

0.54

94

swine

150

150.178

-

26.8742

30.3±
4.7

59.84115

30.68439

94

6.7

161 swine

150

150.178

-

26.8742

42±4

59.84115

30.68439

94

6.7

95

Rat

99

100.094

-

20.685

48/18

41.1873

21.41581

4

0.4

96

Dog

143

142.191

46

19.43323

42±7

47.515

21.56576

0.8

0.1

97

swine

359

358.476

-

29.10781

112±
8.48

77.4706

33.0111

94

6.7

98

swine

90

90.4641

23.25

24.90368

46±7.
5

47.8475

28.38637

94

6.7

99

Rat

99

100.1104

-

20.80742

10

42.32027

21.26861

4.5

0.54

44

swine

99

98.1135

-

25.2926

49±2

49.9177

28.86385

94

6.7

100

Rat

87

233.1

39.6

2

100.1104

20

25

R= Reference, Exp.= Experimental, ParO2 = Arterial PO2, PcmO2 = Coronary Venous PO2,
PtO2 = Cardiac Tissue PO2, Pcm1O2 = Cardiac Subcompartment 1 PO2, Pcm1O2 = Cardiac
Subcompartment 1 PO2, Q۠cm= Myocardial Blood Flow, mrO2cm = Myocardial Oxygen
Consumption.
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Coronary Venous PO2

Model Coronary Venous PO2 (Torr)

45

Model PO2 = 0.742 x Experimental PO2 + 6.812

40
35
30
25
20
15
10
5

0

5

10

15

20

25

30

35

40

45

50

Experimental Coronary Venous PO2 (Torr)

Figure 4.1: Comparison of Coronary Venous PO2.

Comparison of model

predictions of coronary venous PO2 (y-axis) with experimentally measured
coronary venous PO2 (x-axis). (Table 4.1).

The dashed line represents the

regression equation.
Statistical Significance:
Model Coronary Venous PO2 = 0.742 x Experimental Coronary Venous PO2 +
6.812
Standard error of estimate: 3.566
Regression coefficient, R: 0.743
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Subcompartment 1 Tissue PO2

Model Compartment 1 Tissue PO2 (Torr)

70

Model PO2 = 0.918 x Experimental PO2 + 6.532
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Figure 4.2 : Comparison of Myocardial Tissue PO2 in Subcompartment 1.

Comparison of model predictions of myocardial tissue PO2 (y-axis) in
subcompartment 1 with experimentally measured (x-axis) myocardial tissue PO2
(measurement sites close to arterioles or generally large electrode was used).
(Table 4.1). The dashed line represents the regression equation.
Statistical Significance:
Model Compartment 1 PO2 = 0.918 x Experimental Compartment 1 PO2 + 6.532
Standard error of estimate: 6.387
Regression coefficient , R: 0.643
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Subcompartment 2 Tissue PO2

70

Model Compartment 2 Tissue PO2 (Torr)

Model PO2 = 1.396 x Experimental PO2 -8.007
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Figure 4.3: Comparison of Myocardial Tissue PO2 in Subcompartment 2.

Comparison of model predictions of myocardial tissue PO2 (y-axis) in
subcompartment 2 with experimentally measured (x-axis) myocardial tissue PO2
(measurements made with electrodes whose size is comparable to that of size of a
capillary). (Table 4.1). The dashed line represents the regression equation.
Statistical Significance:
Model Compartment 2 PO2 = 1.396 x Experimental Compartment 2 PO2 -8.007
Standard error of estimate: 2.803
Regression coefficient , R: 0.913
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Figure 4.4: Prediction for Short Duration-High Concentration CO Exposure.

Figure shows the predicted %HbCO levels in arterial blood, coronary venous
partial pressure of O2 (PcmvO2), oxygen tension in cardiac subcompartment 1
(Pcm1O2), MbCO levels in cardiac subcompartment 1 (%MbCOcm1), oxygen
tension in cardiac subcompartment 2 (Pcm2O2) and MbCO levels in cardiac
subcompartment 2 (%MbCOcm2) for a short (5min) CO exposure (6683 ppm).
The point (•) shows the start of therapy (room air administration) at t = 5 min,
lasting for 283mins after CO exposure. Simulation time is plotted on the x-axis
and

the

model

predicted

variables
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are

plotted

on

the
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Figure 4.5: Prediction Summary for Short Duration-High Concentration CO

Exposure. Figure shows the predicted %HbCO (blue) levels in arterial blood, %
MbCO levels in cardiac subcompartment 1 (red solid) and cardiac
subcompartment 2 (red dashed), oxygen tension in cardiac subcompartment 1
(green solid) and cardiac subcompartment 2 (green dashed); % MbCO levels in
resting skeletal muscle subcompartment 1 (magenta solid) and resting skeletal
muscle subcompartment 2 (magenta dashed), oxygen tension in skeletal muscle
subcompartment 1 (cyan solid) and skeletal muscle subcompartment 2 (cyan
dashed) for a short (5min) CO exposure (6683 ppm). Simulation time is plotted on
the x-axis and the model predicted variables are plotted on the y-axis.
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Figure 4.6 :Prediction for Long Duration-Low Concentration CO Exposure.

Figure shows the predicted %HbCO levels in arterial blood, coronary venous
partial pressure of O2 (PcmvO2), oxygen tension in cardiac subcompartment 1
(Pcm1O2), MbCO levels in cardiac subcompartment 1 (%MbCOcm1), oxygen
tension in cardiac subcompartment 2 (Pcm2O2) and MbCO levels in cardiac
subcompartment 2 (%MbCOcm2) for a long (480min) CO exposure (90 ppm).
The point (•) shows the start time of CO exposure. Simulation time is plotted on
the x-axis and the model predicted variables are plotted on the y-axis.
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Figure 4.7: CO Rebreathing During 100% O2 Administration. Figure shows the

predicted %HbCO (blue) levels in arterial blood, % MbCO levels in cardiac
subcompartment 1( red solid) and cardiac subcompartment 2 (red dashed),
coronary venous PO2 (blue solid) oxygen tension in cardiac subcompartment
1(green solid) and cardiac subcompartment 2( green dashed) for a period 480
mins with CO concentrations being 90ppm. The point (•) shows the start of CO
exposure. Simulation time is plotted on the x-axis and the model predicted
variables are plotted on the y-axis.
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Figure 4.8: Baseline HbCO (1.9%) at Rest and Three Levels of Exercise. Figure

shows the predicted %HbCO levels in arterial blood, coronary venous partial
pressure of O2 (PcmvO2), oxygen tension in cardiac subcompartment 1(Pcm1O2),
MbCO levels in cardiac subcompartment 1(%MbCOcm1), oxygen tension in
cardiac subcompartment 2(Pcm2O2) and MbCO levels in cardiac subcompartment
2(%MbCOcm2. The points (•) show the end times of 5 min sessions of rest,
exercise 1, exercise 2 and exercise 3. The sessions are simulated at baseline
HbCO levels of 1.9%. Simulation time is plotted on the x-axis and the model
predicted variables are plotted on the y-axis.
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Figure 4.9 : HbCO (10%) at Rest and Three Levels of Exercise. Figure shows the

predicted %HbCO levels in arterial blood, coronary venous partial pressure of O2
(PcmvO2), oxygen tension in cardiac subcompartment 1(Pcm1O2), MbCO levels
in cardiac subcompartment 1(%MbCOcm1), oxygen tension in cardiac
subcompartment 2(Pcm2O2) and MbCO levels in cardiac subcompartment
2(%MbCOcm2. The points (•) show the start times of 5 min sessions of rest,
exercise 1, exercise 2 and exercise 3. The sessions are simulated at baseline
HbCO levels of 10%. Simulation time is plotted on the x-axis and the model
predicted variables are plotted on the y-axis.
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Figure 4.10 : HbCO (20%) at Rest and Three Levels of Exercise. Figure shows

the predicted %HbCO levels in arterial blood, coronary venous partial pressure of
O2 (PcmvO2), oxygen tension in cardiac subcompartment 1(Pcm1O2), MbCO
levels in cardiac subcompartment 1(%MbCOcm1), oxygen tension in cardiac
subcompartment 2(Pcm2O2) and MbCO levels in cardiac subcompartment 2
(%MbCOcm2).The points (•) show the start times of 5 min sessions of rest,
exercise 1, exercise 2 and exercise 3. The sessions are simulated at baseline
HbCO levels of 20%. Simulation time is plotted on the x-axis and the model
predicted variables are plotted on the y-axis.
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Figure 4.11: HbCO (20%) at Rest and Three Levels of Exercise Followed with

100% O2 Treatment. Figure shows the predicted %HbCO levels in arterial blood,
coronary venous partial pressure of O2 (PcmvO2), oxygen tension in cardiac
subcompartment

1(Pcm1O2),

MbCO

levels

in

cardiac

subcompartment

1(%MbCOcm1), oxygen tension in cardiac subcompartment 2(Pcm2O2) and
MbCO levels in cardiac subcompartment 2(%MbCOcm2).The points (•) show the
end times of 5 min sessions of rest, exercise 1, exercise 2, exercise 3 and start
time of 100% O2 breathing for period of 60 mins. The sessions are simulated at
baseline HbCO levels of 20%. Simulation time is plotted on the x-axis and the
model predicted variables are plotted on the y-axis.
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Figure 4.12: Comparison of 100% O2 and Room Air breathing after CO

exposure. Comparison of 100% O2 VS. Room Air Treatment During 20% HbCO
at Rest and Three Levels of Exercise: Figure shows the predicted %HbCO levels
in arterial blood, coronary venous partial pressure of O2 (PcmvO2), oxygen
tension in cardiac subcompartment 1(Pcm1O2), MbCO levels in cardiac
subcompartment 1(%MbCOcm1), oxygen tension in cardiac subcompartment
2(Pcm2O2) and MbCO levels in cardiac subcompartment 2(%MbCOcm2).The
points (•) show the start times of 5 min sessions of rest, exercise 1, exercise 2,
exercise 3 and start time of 100% O2 (blue) or room air (red) breathing for
period of 60 mins. The sessions are simulated at baseline HbCO levels of 20%.
Simulation time is plotted on the x-axis and the model predicted variables are
plotted on the y-axis.
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Figure 4.13: Baseline HbCO (1.9%) - HbCO (5%) - HbCO (15%) (Each session

at Rest and Three Levels of Exercise) Followed with 100% O2 Treatment. Figure
shows the predicted %HbCO (blue) levels in arterial blood, % MbCO levels in
cardiac subcompartment 1( red solid) and cardiac subcompartment 2 (red dashed),
oxygen tension in cardiac subcompartment 1 (green solid) and cardiac
subcompartment 2 ( green dashed). The point (•) shows the 5 min end time
session of rest (-), exercise 1(--), exercise 2 (-.-.-) and exercise 3 (….). The HbCO
level attained are 1.9%, 5% and 15%. Simulation time is plotted on the x-axis
and the model predicted variables are plotted on the y-axis.
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CHAPTER 5
Discussion
This chapter summarizes the modifications made to the selected primary model
(Figure 2.1), and discusses the limitations of the current model, issues related to
parameter estimations, and concerns regarding the model validation and results.
The most essential step in modeling is to determine the exact need for the
model. In this thesis we need the model to predict the amount of CO entering the
blood and the cardiac tissues and to determine the effects of CO on tissue
oxygenation (PcmO2, tissue PO2 of the cardiac compartment). Uptake of CO by blood
can be determined by measuring the COHb levels in the venous blood. But it is
difficult to measure MbCO (carboxymyoglobin) levels and tissue PO2 in the human
heart noninvasively. It is not expected from the model that the predictions be literally
true but one can insist that the models provide useful approximations and their
usefulness is measured against the value of the proposed objectives.
5.1 Model Modifications

The following modifications were made to enhance the model predictions:
5.1.1 Implementing O2 Mass Balance Equations

The primary model (35) has been enhanced and modified in many aspects. CO
impairs O2 delivery to the tissues, so the primary issue is to predict impairment of O2
delivery in the presence of CO and its effect on tissue PO2. At the same time, the
extravascular burden of CO depends on the O2 levels of the tissue. That is, the CO O2 interaction involves a feedback loop, making it difficult to calculate the deliveries
of O2 and CO unless the O2 mass balance equations are included. Thus to predict the
CO load delivered, it is important to understand O2 availability (PO2) in the tissue.
Hence mass balance equations for O2 were added for all compartments of the model.
In the initial model O2 parameters were passed as constants, while in the current
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model all O2 parameters are calculated within the model. They are determined by
solving simultaneous algebraic equations for oxyhemoglobin dissociation curves, and
integrating the differential mass balance equations as described in Section 3.8 of
chapter 3. We know that impaired O2 delivery (CO hypoxia, hypoxic hypoxia,
increased demand for oxygen while performing high stress exercise), and insufficient
O2 availability (coronary artery diseases, occlusion and ischemia) can disturb the
homeostasis of energy metabolism (ATP production), blood flow and O2 pressure
gradients. Incorporating O2 mass balance equations into the model has enhanced the
ability of the model to predict O2 tensions (which are difficult to measure
experimentally) in the cardiac compartment and extended its application to simulate
hypoxia, exercise and other conditions resulting in O2 insufficiency.
5.1.2 Model Architecture and Flow Design

Modifying the model design to incorporate two subcompartments instead of a
single compartment to represent the heart and the skeletal muscle helped in
addressing the limitations related to O2/CO diffusion and arterio-venous shunting, and
the well-known fact that PO2 is not the same throughout a tissue. Maintaining the
balance of the O2 supply and demand is very important in determining tissue oxygen
tension. Attributing the skeletal muscle with regional flow and metabolic demand has
allowed a better prediction of O2 tension and CO load. Blood to tissue oxygen flux
equations (Section 2.1.3, chapter 1) were modified by estimating them as a function
of pressure gradients and the diffusion coefficient of O2 (Section 3.2.2, chapter 3)
instead of making an assumption of equality between O2 flux and metabolic demand
of the compartment (35). Also, in the current model, the nonlinear changes in O2 and
CO are being better accounted for due to improved algorithms (Section 3.8, chapter
3). I also implemented a new algorithm to solve the simultaneous algebraic equations
to calculate the partial pressure of O2 corresponding to the concentration of oxygen
halfway between the inlet and outlet of the vascular subcompartment of the tissue
(Section 3.8, chapter 3).
Adding a Cardiac Compartment to the Model: A two-subcompartment cardiac
compartment was added to the model which is one of the main goals of the thesis.
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The skeletal and cardiac muscle exhibit major differences in anatomy, blood flow,
and O2 demand. Unlike skeletal muscle, cardiac muscle works constantly to pump
blood and it would, therefore, be inappropriate to lump the cardiac muscle with the
resting skeletal muscle. Implementing a cardiac compartment made noninvasive
predictions of MbCO levels and oxygen tension in the tissues possible. These values
are difficult to measure experimentally (noninvasivly) in the human heart.
5.1.3 Physiological Relevance

Regulation of cardiac output with respect to increased blood HbCO
(carboxyhemoglobin) levels was implemented into the model by means of a
predictive equation (68, 69, 70). Blood volume was estimated for individual subjects
by means of a regression equation reported in the literature (78). Estimating
myocardial O2 consumption and myocardial blood flow as a function of heart rate
(increases in heart rate would increase the work load of the heart resulting in higher
O2 demand and increased O2 supply to meet the increased O2 demand) helps in
calculating estimates close to physiological values with increased heart rate.
Permeability surface area product increases linearly with increases in blood flow,
contributing to efficient diffusion of O2 in times of O2 impairment; this phenomenon
was also added to the model.
Model application: Applying these modifications has enhanced the capability of
the model to make predictions of tissue oxygen tension in the human heart during
hypoxic hypoxia, exercise, higher altitude and other O2 insufficiency conditions.
5.2 Model Limitations

The foremost limitation of the model is that it has lumped component
parameters causing aggregation errors. This results in loss of anatomic resolution and
functional representation of the organ, such as in the case of cardiac component layers
of the heart (epicardium, midmyocardium, endocardium) and chambers of the heart
(atria and ventricles) which display varied heterogeneity in blood flow, O2
consumption, capillary density and tissue volume. But if one had to model the cardiac
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muscle tissue for the purpose of this thesis, the best choice to model would be the
region of left ventricular mid myocardium, as this region is especially susceptible to
injury during CO exposure due to its high O2 demand and the fact that CO
interferences cause impairment of O2 delivery. The heart is a dual pump, the left and
right sides of the heart pump blood separately, but simultaneously, into the systemic
and pulmonary systems. In order to pump blood efficiently, it is required for the right
and left atria to contract first followed immediately by contraction of the right or left
ventricle, respectively. Spreading of action potentials from one myocyte to other and
depolarization of the plasma membrane triggers contraction of the cardiac muscle.
Thus, mismatch of O2 supply and demand in the most susceptible left ventricular
myocardial region may cause alterations in myocyte functionality (spreading of action
potential) in this region, resulting in disruption of synchronous functionality
(sequence of excitation) of the heart leading to arrhythmia. Thus, most of the
predictive equations for determining the blood flow and O2 consumption were built
for the left ventricular region (left ventricle and intraventricular septum) of the heart.
When the model was tested using experimentally measured values of regional
myocardial blood flow and O2 consumption as inputs, model predictions of
experimental coronary venous PO2 were able to match the experimental values
obtained as seen from Figure 4.1 of chapter 4. However, limitations due to diffusion
and capillary heterogeneity were overcome to an extent by implementing two
subcompartments. This allowed intertissue diffusion of O2 and CO. Also, using two
subcompartments allowed indirect arterio-venous O2 and CO shunting within the
tissue. However, the design for incorporating two subcompartments instead of a
single

compartment

raises

issues

regarding

the

maximum

number

of

subcompartments that can be implemented. This concern must be considered in
relation to the thesis objective of predicting injury to the heart due to CO exposure.
Our main concern here is to model the CO uptake by the blood and the cardiac tissue.
We are basically predicting the average MbCO and PO2 levels of the tissue by means
of the model. Thus by distributing cardiac muscle into two compartments, we assume
that the first compartment is the tissue perfused with small arterioles and small
venules, as well as by capillaries, and the second compartment is perfused by
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capillaries. By making this assumption, we are making an attempt to understand the
behavior of tissue with respect to its distance from a capillary, arteriole or venule
during CO hypoxia. The MbCO levels and tissue PO2 in the first compartment would
reflect experimental measurements of values made near an arteriole while the second
compartment predictions would be comparable to measurements made in the tissue
close to a capillary. Also, one has to make a trade off between computational expense
and achieved numerical accuracy in model predictions. Thus, considering all these
issues, the two subcompartment cardiac model seems to be a reasonable compromise.
Another limitation of the model is that it does not incorporate details of
metabolic pathways (change from aerobic to anaerobic metabolism), coupling with
electro-physiological events (action potential due to K+, Na+ Ca2+ channels)
regulating coronary venous PO2 (156) and biochemical events (Pcr, pH). The human
heart, being a complex system, has many other backup regulation modules to restore
homeostasis during conditions of diminished O2 availability such as CO exposure or
increase in O2 demand as in exercise. Regulation of cardiac output and heart rate was
implemented into the model by adding predictive equations to estimate variations in
both cardiac output and heart rate as functions of blood HbCO levels. The effect of
vasodilatation and capillary recruitment on blood-tissue gas exchange was
implemented by increasing the permeability surface area product (PScm) as a linear
function of increases in blood flow to the heart. Apart from increases in cardiac
output, HR and vasodilatation which are implemented into the model, there are other
functional mechanisms taking place like the change of metabolic pathways from
aerobic cycle to anaerobic cycle due to diminished O2 levels in tissue, variation in
blood pressure, etc. Also, the role of myoglobin facilitated diffusion and cytochrome
C oxidase interactions with CO is not clear (130,150). Gutierrez (1986), Waller et al.,
(1988), Forster (1970), Holland (1970), Roughton (1964), Sharan et al., (1990) ,
Corpes et al., (1989) have shown the dependence of rate of CO uptake by blood on a
series of chemical reactions of O2 and CO in the blood (association and dissociation
rate coefficients of O2 and CO with Hb), pH and PO2. Representation of kinetics of
O2 and CO with hemoglobin (Hb) in modeling O2 and CO transport in the blood
flowing through pulmonary and systemic circulation is difficult as the order of
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magnitude of association and dissociation rate coefficients of O2 and CO with Hb are
unknown (Sharan et al.,1989). pH was found to have second order effect on CO
uptake. The effects of PO2 were considered in models built by Benignus et al., Bruce
et al. and also in the present model (by solving for the oxyhemoglobin dissociation
curves for Hb and Mb (myoglobin), Haldane equation and blood to tissue O2 flux
equations).
5.3 Parameter Estimation Concerns

Estimating the parameters for a model is a crucial issue. Models have several
parameters, some of which may greatly impact the model behavior while other
parameters may not affect the model behavior at all. The impact of the parameters on
the model behavior becomes important when there is scarce or no data available for
the parameters. In such cases sensitivity analysis is conducted for the parameters to
determine their impact on model behavior. For the cardiac compartment in the model,
average values from experimental data were considered for most of the parameters.
Predictive equations were developed for estimating myocardial blood flow and
oxygen consumption.
Prediction formulas were also used to estimate cardiac output and heart rate
when actual values were not available. Subject variability is one major concern in
using average values or prediction equations to estimate parameters. The estimates
made for the parameters using predictive formulas would be valid for a specific group
(age, ethnicity, gender, geographical area being at higher altitudes or below sea level,
method of measurement) from which they were developed. Appling a prediction
equation or an average value obtained from a specific subject group to a varied
population set may tend to underestimate or overestimate the model predictions.
However, after developing these formulas, their statistical significance and validity
were tested for data which were not used for developing the relationships (Section
3.5, chapter 3). For predicting the myocardial O2 consumption and myocardial blood
flow, a more reliable prediction could have been made by calculating the estimates
from heart rate-blood pressure product. But blood pressure was unavailable for many
databases we planned to simulate although heart rate was a parameter which was
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readily available and can also be calculated from total body metabolic rate. But no
such relationship could be applied to estimate blood pressure as it is a greatly varying
physiological parameter. Predicting myocardial O2 consumption and blood flow as
functions of cardiac output seems to be an alternative estimation approach, but
information supporting functional relations between cardiac output, myocardial O2
consumption and blood flow is currently unavailable in the literature.
Estimating a value for resting permeability surface area product for the two
cardiac subcompartments was very difficult due to unavailability of data. The initial
guess values were obtained from models from Beard and Bassinghwaite and then the
resting values were scaled to match the size of the tissue, type of the tissue, and the
species. The permeability surface area products increased as a linear function of
blood flow. This was to indirectly implement coronary vasodilatation and capillary
recruitment into the model.
The values for distribution of volume in each of the compartments (Fvcm) and
for the fraction of venous cardiac blood compartment 3 perfusing the tissue
compartment 1 was estimated by analyzing data available on vascular distribution in
heart, coronary physiology, and statistics on density of arterioles, capillaries and
venules in the heart (103,104). The sensitivity analysis of these parameters is shown
in table 3.8 of chapter 3, so that one can estimate the deviations in the predicted
model values for variation in the parameters (to which model predictions are
sensitive).
5.4 Model Validation Concerns

The major concern in validating the model was unavailability of human data for
testing the model predictions. Animal data, however, were available for model
validation. Data are shown in table 4.1. One can see from the table the extent of
variability and heterogeneity in the data available. Though data for dogs, swine and
rats were available, the experimental values obtained from experiments involving
swine were emphasized due to the similarity with human coronary anatomy and
vasculature. Also, most of the data available are from anesthetized animals. Type of
anesthesia used in the experiment can have a significant effect on the experimental
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values measured (96). Another issue related to the experimental data available is the
method of measurement. Most of the methods available for measuring myocardial
tissue O2 tension are invasive. Reported values may have 10- 15% error due to the
measurement electrodes consuming O2, errors due to diffusion of oxygen from blood
or tissue to the electrode, shift in electrode position due to beating of the heart etc.
Also insertion of the some electrodes (like needle electrodes) causes damage to tissue
and cells and bleeding, thereby possibly contaminating the measured values. From the
Figures 4.1-4.3 shown in chapter 4, it can be seen that coronary venous PO2 and
compartmental tissue PO2 model predictions are close to the experimental values.
Also, the predicted myocardial tissue PO2’s are in agreement with other models (95,
101,104) that utilized a single heart compartment or a distributed (finite-element)
model.
5.5 Concerns Related to Simulated Experiments

In this model heart rate is required to estimate myocardial O2 consumption and
blood flow. In the experimental data provided by Benignus et. al and Burge &
Skinner, heart rate information is unavailable. Heart rate might have been estimated
by using the regression equation described in Section 3.5.3 of chapter 3, where heart
rate is calculated as a function of total body O2 consumption. But total body O2
consumption was not measured by the investigators (Benignus et. al and Burge &
Skinner), thus heart rate for simulations in Section 4.2.1- 4.2.3 was estimated using an
average metabolic rate of 0.0032 ml/gm/min. Total body O2 consumption, heart rate,
myocardial O2 consumption and blood flow estimated in the model may differ from
actual values at the time of experiments. Errors in estimation of the above parameters,
especially heart rate, may have significant effects on the model predictions. For
simulations having exercise sessions (Section 4.2.4), CO diffusion coefficient of
lungs (DLCO), shunt fraction SF are assumed to be constants. Zavorsky et al. (2004),
Demirjian (1980) and Paoletti (1985) have reported age dependent changes in DLCO
with varying exercise intensity. Also the shunt fraction is reported to increase with
increases in exercise intensity (159, 160).
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5.6 Simulation Findings

In all the simulations of Section 4.2, except for the simulation in Section 4.2.3 (where
the subject rebreathes CO during 100% O2), the MbCO levels of cardiac
subcompartment 2 (MbCOcm2) are higher than the MbCO levels in subcompartment
1 (MbCOcm1). Higher MbCO levels in subcompartment 2 may be explained as
follows: when CO is inhaled, it diffuses through the lung and binds with Hb in blood,
resulting in elevated HbCO levels. CO then leaves blood and diffuses into the cardiac
subcompartment 1, resulting in increased MbCO levels in the compartment initially.
CO then diffuses into subcompartment 2 from the blood subcompartment 2 and also
from the tissue subcompartment 1, thereby resulting in higher MbCO levels in
subcompartment 2. Also, with increase in blood HbCO levels the cardiac output
increases. Increased cardiac output would result in increased myocardial O2
consumption and myocardial blood flow. This means that CO delivery to the heart
increases with increase in cardiac blood flow, resulting in increased myocardial O2
consumption and fall in tissue PO2, facilitating an increase in MbCO. This effect is
more significant in the subcompartment 2 as the amount of CO delivered, blood flow
and metabolic rate of this subcompartment is greater than subcompartment 1 resulting
in lower tissue PO2 and higher MbCO levels. In the case of the simulation of CO
rebreathing during 100% O2, the MbCO levels in the two subcompartments reach
equilibrium after few minutes as seen in Figure 4.7 of chapter 4. The HbCO and
MbCO levels are 10% and 4.5%, respectively, and the PO2 in the cardiac
subcompartments decreases by ~1-2 Torr from base line. The reason for the heart
compartments not being hypoxic during CO rebreathing is that the subject is
breathing 100% O2. During hyperoxia, dissolved O2 plays a major role in tissue
oxygenation. At the end of the simulation although the subject breaths 100% O2, a
significant increase in PO2 of cardiac subcompartment 2 is not seen.
Another interesting observation in all the simulations discussed in Section 4.4.4 is
that the MbCO levels of the two tissue subcompartments increase with exercise,
though the HbCO levels are maintained constant. This means that increase in exercise
increases the CO load on heart due to increased blood flow. Also, increased intensity
of exercise causes a rise in O2 consumption, requiring higher O2 demand, thus
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resulting in tissue hypoxia. This observation also supports the reported observations
of a higher risk of cardiac injury in a working population exposed to CO.
The developed model is capable of predicting myocardial tissue and blood PO2
during all transients (different exercise sessions at different HbCO levels, long and
short CO exposures etc) in the simulations. However, tissue PO2 in cardiac
subcompartment 2 being maintained at 19 torr during hyperoxia (administration of
100% O2 after 3 graded levels of exercise with 20% HbCO) after 60 min of breathing
100% O2 seems to be a concern. Prediction of lower PO2 during hyperoxia may be
due to the following reason: insufficient treatment time (simulation can be done by
increasing the treatment time from 60 mins to 300-400 mins and see if the PO2 in
subcompartment 2 increases), or due to errors in model parameters in the treatment
protocol (as parameters were not measured by the investigators).
Decreases in coronary venous PO2 with increased exercise intensity have been
reported (156). The cardiac compartment venous PO2 decreases with exercise as seen
from Figure 4.5. However changes in coronary venous PO2 during combined exercise
and CO exposure have not been reported in human or swine in the current literature.
Thus validating the simulation results becomes difficult. Tissue PO2 of 6-7 Torr have
been reported in mild exercising skeletal muscle tissue of humans whose steady state
resting values at baseline HbCO levels are 35 Torr (158). An average myocardial
tissue PO2 of 3.36 Torr at the end of third stage of moderate exercise (E3) at 20%
HbCO levels seems reasonable. Prediction of tissue PO2 by the model in the range of
0.5-1 Torr for a time span of 8-9 mins may be considered lethal (75,130,132,133).
The model can be validated further if experimentally measured data for myocardial
blood and tissue PO2 would be available in humans or swine during CO exposures at
rest, exercise, hyperoxia and O2 hypoxia.
As seen in Figure 4.5 there is a sharp increase in the MbCO levels of the cardiac
compartments with increase in HbCO levels of the blood, whereas the MbCO levels
of the skeletal muscle increase gradually after the HbCO blood levels decrease. This
sharp immediate increase in MbCO levels suggest that the CO released from
hemoglobin binds to the myoglobin present in the cardiac muscle. Also the cardiac
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tissue PO2 decreases with increases in HbCO and MbCO levels, suggesting greater
risk of injury than skeletal muscle. The cardiac muscle has higher O2 consumption,
blood flow and capillary density than that of resting skeletal muscle and
unavailability of O2 store would result in greater degree of hypoxia. As seen in Figure
4.6, during long-low CO exposure the MbCO levels of the cardiac compartment
increase with increase in HbCO levels and after a certain amount of time exceed
HbCO levels in the blood, suggesting that myocardial tissue hypoxia is the
combination of impaired O2 carrying capacity of blood and impaired O2 storage in
myoglobin. Thus one can confirm that the response of various tissue to CO exposure
is different, based on their functionality and oxygen consumption. Thus it would not
be valid to apply the same response to all the tissues.
The hypothesis tested for the thesis was that during CO exposures and subsequent
therapies, the temporal changes of %MbCO in the heart differ from those of %HbCO
was tested. From the various simulations, it was found that HbCO and MbCO levels
in the heart greatly depend on the type of CO exposure. In the case of short-high CO
exposures, the MbCO levels positively correlate with HbCO, while in long-low CO
exposures, the MbCO levels increase with increasing HbCO initially but later increase
to levels higher than blood HbCO levels. During exercise though the HbCO levels are
constant, the MbCO levels increase resulting in decreased tissue oxygen tensions.
Thus, the results obtained support the hypothesis made. The CO load is related to
both %HbCO in arterial blood perfusing the heart and %MbCO in cardiac tissue. In
long-low CO exposures myocardial hypoxia occurs due to impaired O2 transport
(decrease in %HbO2) and unavailability of O2 storage (%MbO2) where as in shorthigh CO exposures, tissue hypoxia is mainly due to impaired O2 transport and in
exercise protocols the cardiac hypoxia is mainly due to unavailability of O2 storage
(%MbCO). Thus basing the treatment on the currently-used clinical indicator of
potential injury (i.e., %HbCO) will be inaccurate and possibly misleading. Thus,
determining the total CO load on the cardiac cells (or its effect on tissue PO2) is likely
to be a better predictor of injury.
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Overall, the developed model proves to be an excellent tool for predicting
extravascular burden (MbCO levels and tissue PO2) of CO on human heart.
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CHAPTER 6
Conclusion
Noninvasive measurement of myocardial tissue PtO2 and MbCO levels during or after
CO exposure is difficult. The main goal of the thesis was to develop a model that is
capable of predicting extravascular burden of CO in the human heart and its effects
on tissue oxygenation. A multi compartment model was developed consisting of six
major compartments: 1.The arterial blood, 2. The Lungs, 3. Skeletal Muscle with two
subcompartments,

4.

Non-muscle

tissue,

5.

Cardiac

Muscle

with

two

subcompartments and 6. Mixed venous blood compartments. Mass balance equations
are written for O2 and CO for each of these compartments. In each blood
compartment, to determine PO2, PCO and O2 flux we solve three simultaneous
algebraic equations: the oxyhemoglobin dissociation curve, Haldane’s equation, and
the blood-to-tissue flux equation for oxygen. Myocardial blood flow and oxygen
consumption are estimated from regression equations developed for the thesis. The
model is simulated on a Windows XP system using ACSL™ software which is
capable of solving nonlinear differential equations. Sensitivity analysis is performed
and the myocardial tissue PO2 (PtO2) is shown to be sensitive to myocardial blood
flow, myocardial oxygen consumption, volume distribution fraction of the tissue,
diffusion coefficient of O2 and the permeability surface area product. The developed
model was used for the simulations to test the validity of the predicted variables of
the cardiac compartment with published observations on human subjects and
anesthetized animals. The model was validated for conditions of normoxic rest,
hypoxic rest, hypoxic exercise and hyperoxia with regard to its predictions of
coronary venous PO2 and tissue PO2. Simulation of short-high concentration CO
exposure, long-low concentration CO exposure, CO rebreathing during 100% O2
administration and CO exposure during rest and exercise sessions for different levels
of HbCO have been analyzed. In short-high concentration exposures, the tissue
MbCO levels increase sharply unlike in long-low concentration exposures where the
MbCO levels increase gradually. The tissue PO2 levels seem to be correlated more
with %HbCO levels than with %MbCO levels in short-high CO exposures. This
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would suggest that there is impaired O2 delivery to tissues due to impaired O2
transport. During long-low CO exposures, the tissue PO2 correlates with MbCO
levels i.e., it decreases with increase in MbCO. In the simulation where subject
rebreathes CO during 100% O2 administration, the tissue PO2‘s correlate with
%HbCO levels and %MbCO levels increase with corresponding decreases in %HbCO
levels suggesting that during hyperoxia, CO dislodged from hemoglobin is taken up
by myoglobin. During exercise, the tissue PO2‘s are strongly correlated with MbCO
levels, suggesting that myocardial tissue hypoxia occurs during elevated levels of
MbCO. Also, during room air treatment the MbCO and HbCO levels fall slowly
compared to treatment with 100% O2, indicating that 100% O2 can be an effective
treatment for CO hypoxia in cardiac muscle. The hypothesis that CO load (%HbCO,
%MbCO) delivered to the heart impairs oxygen delivery further affecting the tissue
oxygen tension (PtO2). Thus during CO exposures and therapies, the temporal
changes of %MbCO in the heart differ from those of %HbCO depending on the type
of exposure. %MbCO levels can increase when %HbCO is maintained constant
(during exercise) or is decreasing (in case of hyperoxia treatment). This CO load is
related to both %HbCO in arterial blood perfusing the heart and %MbCO in cardiac
tissue.

The correlation of %HbCO, %MbCO and tissue PO2 should be clearly

understood for different types of CO exposure to consider them as clinical indicators
of potential injury. The decreasing tissue PO2 in the cardiac muscle during short-high
CO exposure correlates with increasing %HbCO levels while the %MbCO of skeletal
muscle shows a correlation with %HbCO after a delay. The %MbCO levels of the
cardiac compartment show sharp increases unlike gradual increases as seen in skeletal
muscle. This is a very important observation as it emphasizes the fact that cardiac
muscle is at higher risk than resting skeletal muscle. During elevated %MbCO levels,
the PO2 stores may diminish resulting in the tissue being further hypoxic.
The cardiac muscle is a rigorously working muscle with high metabolic demands
for oxygen. Myoglobin provides the storage site for O2 in times of increased O2
demand. During CO exposure the storage site of O2 is lost as CO binds to myoglobin,
resulting in increased %MbCO levels and tissue oxygen deprivation, thus resulting in
severe hypoxia. A tissue PO2 in the range of 0.5 to 1 Torr is assumed to be indicative
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of injury. O2 is needed for the heart to maintain its functions and lack of O2 supply
can cause severe injury to the tissue. Thus the risk of injury would be greater when
someone is exercising and is exposed to CO. Also in a patient population with
congestive heart failure or coronary artery disease where myocardial perfusion is not
normal, exercise or exposure to CO may be fatal to the myocardial tissue.
Thus, determining the CO load on the cardiac tissue seems to be an important
predictor of injury. The model proves to be an effective tool for noninvasive
determination of the MbCO levels and oxygen tensions in a human heart during and
after CO exposure.
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CHAPTER 7
Future Work
1) Compare CO dose to myocardium with occurrence of abnormal features in ECG
(ElectroCardioGram). Myocardial hypoxia during CO exposures has been
reported to produce changes in ECG (S-T segment elevation, QT dispersion, T
wave changes). The extent to which the CO load (HbCO and MbCO levels)
contributes to ECG alterations seen in CO poisoning victims is unknown.
Assesing the correlations between the occurrence of predicted peak MbCO and
HbCO levels with occurrence of abnormalities in ECG will aid in understanding
the CO poisoning related increased risk of cardiac injury.
2) Investigate effects of DcmCO (diffusion coefficient of CO for cardiac muscle) in
exercise. Determination of DcmCO is difficult. The time for blood-tissue
equilibrium of partial pressure of CO is dependent on DcmCO. The rate of
exchange of CO between tissues and blood is determined by the value of DcmCO,
thus determining the values for this parameter is important. If a large value of
DcmCO better explains data, it would imply that the equilibrium between tissue
and blood occurs at a faster rate, but if a smaller value for DcmCO would better
fit the data, then it would support the concept of slow equilibration between tissue
and blood. Understanding the effects of DcmCO during exercise will result in
further understanding the value for DcmCO.
3) Prediction of the extravascular burden for all subjects of references 69,154,155.
Applying the model to predict extravasuclar burden and assessing the produced
response for different types of CO exposure conditions and population will help in
improving the validation of the model. Also, if the same kind of response is
displayed by the subject population, then the result can be better trusted. By
fitting the model to a number of individuals, we can determine the mean as well
as the range of responses in the normal population.
4) Implement changes in DLCO (diffusion coefficient of CO in lungs) and SF (shunt
fraction) with exercise. Adding effects of changing DLCO and SF into the model
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as function of exercise intensity, age, gender etc. will further enhance the
accuracy of model predictions.
5) Predict CO burden on different regions (epicardium, endocardium) and chambers
of the heart. Knowing that the heart displays heterogeneity in blood flow,
capillary density, oxygen consumption etc., it would be interesting to predict
cardiac injury in various regions to determine the region at higher risk for injury
with CO exposure.
6) Conduct experiments in swine to measure myocardial O2 consumption,
myocardial blood flow, heart rate, blood lactate levels, weight of the heart,
multiple measurements of myocardial tissue PO2 in various regions of the heart,
coronary venous PO2, myocardial arterial PO2 during rest, graded levels of
exercise, hypoxic hypoxia and CO hypoxia in order to validate the model. There
is scarce data available in the literature for efficiently validating the model. Thus,
if one conducts an experiment and measures all the above parameters, then the
model can be better validated and also determination of parameters like
permeability surface area product etc., will be more reasonable.
7) Design effective treatment protocols. As seen from the results, the CO load would
differ with type (short-high, long-low or during exercise) of CO exposure, thus it
would not be advisable to treat all the CO - poisoned victims with the same
protocol. Using the model to simulate different treatment protocols that may
include mixed session of room air, 100% O2 breathing or hyperbaric treatment to
improve tissue oxygenation will be a effective approach for efficient treatment
strategies. The model may use the CO victim’s parameters and simulate different
treatment protocols, which would be quick and easy to accomplish unlike
conducting clinical trials.
8) Estimate concentration and duration of CO exposure after the fact. Knowing the
concentration and time for which the victim was subjected to CO would better
determine the load of CO on organs at high risk like heart and brain during
exposure and treatment. If it is a short CO exposure at high concentrations, then
myocardial hypoxia would be produced due to impaired O2 capacity of blood
unlike in long-low CO concentration CO exposures, where tissue hypoxia is
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produced due to impaired O2 transport accompanied with impaired O2 storage as
hemoglobin as well as myoglobin are bound to CO. Thus, estimating
concentration and duration of CO exposure would be very crucial in designing an
effective treatment protocol. .
9) Implement equations for CO2 in to the model. During both exercise and hypoxic
hypoxia, the tissue PO2 are dependent on the partial pressure of CO.. Thus
implementing equation for CO2 into the model will enhance the model to better
predict the tissue PO2 and also conditions of hypoxic hypoxia can be better
predicted. Also the effects of pH can be implemented into the model. These
additions will result in enhanced model predictions as the oxygen dissociation
curve which is solved to determine tissue PO2 and PCO would be dependent on
CO2 and pH.
10) Modify the model to predict myocardial oxygen tension in patient population with
coronary artery diseases etc. The model can also be used to predict myocardial O2
tensions apart from using it for predicting MbCO and HbCO levels. Generally in
patients with coronary artery diseases, there is decreased blood flow to the heart
due to narrowed or blocked arteries. Thus the blood flow to the myocardium can
be reduced depending on the degree of blockage and myocardial oxygen tensions
can be predicted. Also, conditions of exercise can be simulated for this population
and the predicted myocardial tissue PO2‘s can be correlated with abnormalities in
ECG.
11) The model can also be modified for predicting outcomes of hyperbaric O2
treatment. It is often debated if hyperbaric (breathing 100% O2 at 2-3 ATA)
treatment would have better treatment outcomes than hyperoxia treatment
(breathing 100% O2).
12) Implementing metabolic pathways into the model may be suggested to understand
the effects on model prediction with changes in metabolic cycles from aerobic to
anerobic during exercise, hypoxia or ischemia.
13) Introduce interactions of cytochrome c oxidase with CO. Cytochrome c oxidase is
also known to bind irreversibly with CO. Understanding the contribution of this
protein will further enhance the knowledge database for CO toxicity.
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Appendix
Skeletal muscle mass distributed to trunk muscle, leg muscle and arm muscle:
Oxygen consumption for the skeletal muscle was found to be 250% of total body oxygen
consumption at rest when calculated in the simulated model. According to the following
books;
1. An introduction to cardiovascular physiology by J.Rodney Levick
2. Medical physiology by Philip Bard
Muscle metabolic rate (MRO2m) should be 20% of the total body oxygen consumption
(MRO2). It is known that metabolic rates of leg, arm and trunk muscles are different.
Thus, to incorporate different metabolic rates of muscle in various regions we distributed
the skeletal mass into three muscle volume compartments namely leg muscle volume,
arm muscle volume and trunk muscle volume. Distributions of skeletal mass were
calculated from the references 105-115. From the papers we had data for lean mass of
trunk, arms, legs, upper legs, upper arms and also total skeletal mass. Data were entered
only from normal men and women. The abbreviations used are as follows:
%asm: percent arm skeletal mass
%tsm: percent trunk skeletal mass
%lsm: percent leg skeletal mass
The final result obtained after taking average of data obtained :
MEN:

WOMEN:

%lsm

%asm

%tsm

46.63981 15.66698 37.76795

%lsm

%asm

%tsm

49.52738 13.96499 36.50763

Validation for the relationship obtained was done by selecting a random subject record
from the database and calculating the values using the obtained relationship and
comparing them with the measured values. The differences in the values can be explained
as follows:
1. Total lean soft tissue included muscle as well as soft tissue
2. Reference involved study on Japanese subjects in the age group of 19-24yrs. We
know that muscle mass is effected with age and also ethnicity.
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3. Also one can consider errors due to averaging, pooling data from various sources
which have different methods of measurement, varying number of subjects,
different age population, ethnicity etc.
gender

Men

(total lean soft tissue= Women (total lean soft tissue=

57.8kg)

40kg)

parameter

lsm

asm

tsm

lsm

asm

tsm

measured

20.9

8.7

28.2

14.8

4.9

20.3

calculated

26.9

9.05

21.82

19.8

5.58

14.6

Prediction equation for cardiac output:

Equation to predict the cardiac output in the initial model was based on gender and body
weight. Q . = (54.1 + 7.9G ).BW + 1400 − 200.G
But after modifying the model, we intended to simulate experiments that involved
exercise, CO exposure etc. It was clear that cardiac output Q۠ changed with exercise,
postural changes and age. Thus to implement variation of cardiac output, we
implemented the following prediction equation,
Q˙ =3.186+7.346* (MRO2)-0.535*(MRO2)2
Where, cardiac output Q˙ is calculated as a quadratic expression function of total body
metabolic rate (MRO2). Also this equation was very helpful in predicting the cardiac
output when experimental data did not provide the value. Literature survey established
the fact that cardiac output can best be predicted as a function of total body oxygen
consumption (references). Thus, to work on this idea, various journals were searched for
data from humans at rest and exercise for cardiac output and total body oxygen
consumption (MRO2).The inclusive criterion for the data was that it was considered from
healthy, non smoking untrained individual subjects. The method of measurement for
MRO2 was either Fick’s method or the Douglas bag method. Cardiac output was
calculated from dye dilution method, Fick’s method etc. Though the measurement
techniques were different, the values obtained for cardiac output for specific oxygen body
consumption did not vary significantly. Data from references 137-144 were used to
implement the relationship. The reason for building a quadratic expression was to have a
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regression relation with strong statistical significance and also cardiac output is known to
reach a plateau as maximal body oxygen consumption is reached.
30

Cardiac Output - Q. (l/min)

25

20

15

10
Original data
Regression data
Test data 1
predicted data 1
Test data 2
predicted data 2

5

0

0

1

2
3
4
Body Oxygen Consumption - VO2 (l/min)

5

6

Figure above shows the plot of the data (o) used to build the relationship and predicted
data (*). On the X-axis we have the myocardial O2 consumption and on the Y-axis is the
cardiac output. Test data points (o,o) were considered from experiments whose data were
not included in building the relation to check with the values(*,*) obtained from the
predictor equation. Cardiac output (Q˙) and myocardial oxygen consumption (MRO2) are
specified and calculated in the unit of liter/min. When implemented into the model they
are converted into milliliter. MRO2 is in STPD and is converted to BTPS in the model.
Order of relation

Regression coefficient

Error of estimate

Q• = b.MRO2 +c

0.907

1.949

Q• = a.(MRO2)2+b.MRO2+ c

0.962

1.75

Prediction equations for Heart rate: In most of the experiments, heart rate was

mentioned. But in the case of data where information regarding heart rate was missing, it
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was estimated from the following equation: Heart Rate (HR) =42.819+68.884*(MRO2)8.26* (MRO2)2
The main purpose for developing a prediction equation for heart rate was to estimate the
myocardial blood flow and myocardial oxygen consumption for the cardiac compartment
discussed in Chapter 3. Heart rate is often considered to be a predictor of extent of
myocardial activity. Heart rate and blood pressure product would have been a better
predictor of myocardial parameters like myocardial blood flow and oxygen consumption
than just heart rate. But it was difficult to predict blood pressure from body oxygen
consumption or cardiac output due to unavailability of sufficient data. Thus, heart rate
was expressed as a function of MRO2.

The following references (68-70), were

considered to obtain a relationship between heart rate (HR) and body oxygen
consumption (MRO2).
220
200
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6

Figure above shows the plot of the data (o) used to build the relationship and predicted
data (*). On the X-axis we have the myocardial O2 consumption and on the Y-axis is the
Heart rate. Test data points (o,o) were considered from experiments whose data was not
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used to estimate the above regression relation to check with the values(*,*) obtained from
the predictor equation.
Order of relation

Regression coefficient

Error of estimate

HR = b.MRO2 +c

0.592

23.678

HR = a.(MRO2)2+b.MRO2+ c

0.664

21.5

Predicting percent increases in cardiac output (Q•) and heart rate (HR) as functions
of percent carboxyhemoglobin (%∆ COHb) levels in blood:

There is a reported increase in cardiac output and heart rate with increase in
carboxyhemoglobin levels in blood (68, 69). While simulating experiments involving
carbon monoxide (CO) exposures, increased cardiac output and heart rate due to
increased carboxyhemoglobin levels in the blood had to be taken into account. These
increases were implemented by introducing the following equations
%∆Q• =0.572 x ( %∆COHb)
%∆HR =0.012 x (%∆COHb) 2 + 0.26 x (%∆COHb)
The cardiac output Q˙ and heart rate (HR) were increased by %∆Q and %∆HR,
respectively, calculated from the above equations in the discrete section of the program.
Data for cardiac output, heart rate and carboxyhemoglobin (up to 50%) were tabulated
from references 68,69.
Linear regression was performed on the data. Outliers of the data were removed.
Statistical significance of the relationships was tested and the best relation was chosen
and implemented into the model to incorporate the changing effects in cardiac output and
heart rate with increasing CO levels in the body.
Cardiac output and Carboxyhemoglobin levels in blood:
Order of relation

Regression coefficient

Error estimate

0.377

15.155

%∆Q =a(%∆COHb) +b(%∆COHb)+c

0.178

15.184

%∆Q• =a ( %∆COHb)

0.713

12.483

%∆Q• =a ( %∆COHb) + c
•

2
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Percent increase in Cardiac output - %/\Q
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Figure above shows the plot of the data (o) used to build the relationship and predicted
data (*). On the X-axis we have the percent increase in carboxyhemoglobin levels of
blood, %∆COHb and on the Y-axis is the percent increase in cardiac output, %∆Q•.
Cardiac output and Carboxyhemoglobin levels in blood:
Figure below shows the plot of the data (o) used to build the relationship and predicted
data (*). On the X-axis we have the percent increase in carboxyhemoglobin levels of
blood, %∆COHb and on the Y-axis is the percent increase in cardiac output, %∆HR.
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70

Percent increase in Heart Rate - %/\HR
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Order of relation

Regression coefficient

Error estimate

%∆HR=a(%∆COHb)2+b(%∆COHb)+c

0.422

9.962

%∆HR=a(%∆COHb)2 +c

0.422

9.961

%∆HR=a(%∆COHb)2+b(%∆COHb)

0.612

9.958
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